UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C.D. C. 20549

FORM 10-Q

x

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterlyquarterly period endedJune 30, 2017

March 31, 2020

OR

¨TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____ to ____
Commission file numbernumber: 333-60608

JANEL CORPORATION

(Exact name of registrant as specified in its charter)
Nevada 86-1005291
(State or other jurisdiction of(I.R.S. Employer
incorporation or organization) (I.R.S. Employer Identification No.)


303 Merrick Road – Suite 40080 Eighth Avenue  
Lynbrook, New York, New York 1156310011
(Address of principal executive offices) (Zip Code)


Registrant’s telephone number, including area code:(516) 256-8143

(

Former name, former address and former fiscal year, if changed from last report.)

report: N/A

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading symbols(s)
Name of each exchange
on which registered
NoneNoneNone

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yesx   No¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yesx   No¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer
¨Accelerated filer¨
Non-accelerated filer
¨   ☐Smaller reporting companyx
(Do not check if a smaller reporting company)Emerging growth company¨


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).

Yes¨  Nox

The number of shares of Common Stock outstanding as of August 4, 2017May 11, 2020 was 553,951.

850,652.
 



JANEL CORPORATION

QUARTERLY REPORT ON FORM 10-Q

For Quarterly Period EndedJune 30, 2017

 March 31, 2020

TABLE OF CONTENTS

 Page
  
Part I - Financial Information
3
  
 
Item 1.
Financial Statements:Statements
Consolidated Balance Sheets as of
June 30, 2017 (unaudited) and September 30, 2016
3
    
  
Consolidated Balance Sheets as of March 31, 2020 (unaudited) and September 30, 2019
3
Consolidated Statements of Operations
for the Three and NineSix Months Ended June 30, 2017ended March 31, 2020, and 2016

2019 (unaudited)
4
    
  
Consolidated Statement of Changes in Stockholders’ Equity
for the NineSix Months Ended June 30, 2017ended March 31, 2020 and 2019 (unaudited)
5
    
  
Consolidated Statements of Cash Flows
for the NineSix Months Ended June 30, 2017ended March 31, 2020 and 20162019 (unaudited)
6
    
  
Notes to Consolidated Financial Statements (unaudited)
7
    
 
Item 2.
Management’s Discussion and Analysis of
Financial Condition and Results of Operations
1226
    
 
Item 4.
Controls and Procedures
1839
    
Part II - Other Information
41
 
Item 1.
Legal Proceedings
41
    
 
Item 1.1A.
Legal ProceedingsRisk Factors
1942
    
 
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
43
Item 6.
Exhibit Index
1943
    
  
Signatures
2144

- 2 -

2


Table of Contents
PART I - FINANCIAL INFORMATION

ITEM 1.FINANCIAL STATEMENTS

JANEL CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

  June 30,  September 30, 
  2017  2016 
  (unaudited)    
ASSETS        
CURRENT ASSETS        
Cash and cash equivalents $1,889,468  $965,115 
Accounts receivable, net of allowance for doubtful accounts of $242,270 and $230,000, respectively  13,323,679   12,353,582 
Inventory  332,365   356,875 
Prepaid expenses and sundry current assets  314,059   233,716 
Total current assets  15,859,571   13,909,288 
PROPERTY AND EQUIPMENT, NET  338,218   287,391 
OTHER ASSETS        
Intangible assets, net (Note 3)  12,041,771   12,373,266 
Goodwill  9,101,858   8,443,477 
Deferred income taxes  587,983   844,977 
Security deposits  122,246   99,658 
Total other assets  21,853,858   21,761,378 
Total assets $38,051,647  $35,958,057 
         
LIABILITIES AND STOCKHOLDERS' EQUITY        
CURRENT LIABILITIES        
Notes payable - banks (Note 4) $6,674,311  $6,498,403 
Note payable - related party, net of imputed interest (Note 5)  492,635   500,000 
Accounts payable - trade  11,635,006   9,298,029 
Accrued expenses and other current liabilities  1,832,335   1,254,926 
Dividends payable  994,945   623,077 
Note payable – other  -   - 
Current portion of long-term debt  857,148   857,148 
Total current liabilities  22,486,380   19,031,583 
OTHER LIABILTIES        
LONG-TERM DEBT – BANK        
Long-term debt (Note 4)  3,640,179   4,616,540 
Long-term debt - related party, net of imputed interest (Note 5)  -   471,108 
Deferred compensation  78,568   78,568 
Total other liabilities  3,718,747   5,166,216 
Total liabilities  26,205,127   24,197,799 
STOCKHOLDERS' EQUITY        
Preferred stock, $0.001 par value; 100,000 shares authorized        
Series A 20,000 shares authorized and 20,000 shares issued and outstanding at both dates  20   20 
Series B 5,700 shares authorized and 1,271 shares issued and outstanding at both dates  1   1 
Series C 20,000 shares authorized and 14,205 shares issued and outstanding at both dates  15   15 
Common stock, $0.001 par value; 4,500,000 shares authorized, 573,951 shares issued and 553,951 and 573,951 shares outstanding, respectively  574   574 
Paid-in capital  12,710,441   12,920,416 
Treasury stock, at cost 20,000 shares (Note 6)  (240,000)  - 
Accumulated deficit  (1,700,803)  (2,161,994)
Total Janel Corporation stockholders' equity  10,770,248   10,759,032 
Non-controlling interest  1,076,272   1,001,226 
Total stockholders' equity  11,846,520   11,760,258 
Total liabilities and stockholders' equity $38,051,647  $35,958,057 

(dollars in thousands, except share and per share data)
  
March 31, 2020
(Unaudited)
  
September 30,
2019
 
ASSETS      
Current Assets:      
Cash 
$
1,928  
$
2,163 
Accounts receivable, net of allowance for doubtful accounts  13,677   21,351 
Inventory, net  4,178   4,371 
Prepaid expenses and other current assets  349   531 
Note receivable  
142
   
139
 
Total current assets  
20,274
   
28,555
 
Property and Equipment, net  
3,992
   
3,954
 
Other Assets:        
Intangible assets, net  13,112   13,598 
Goodwill  13,641   13,525 
Operating lease right of use asset  1,599    
Security deposits and other long term assets  
250
   
87
 
Total other assets  
28,602
   
27,210
 
Total assets 
$
52,868
  
$
59,719
 
LIABILITIES AND STOCKHOLDERS’ EQUITY        
Current Liabilities:        
Line of credit 
$
7,533  
$
8,391 
Accounts payable – trade  15,314   22,061 
Accrued expenses and other current liabilities  2,891   2,272 
Dividends payable  1,366   1,041 
Current portion of operating lease liabilities  479    
Current portion of subordinated promissory note  155   152 
Current portion of long-term debt  
838
   
828
 
Total current liabilities  28,576   34,745 
Other Liabilities:        
Long-term debt  6,310   6,602 
Subordinated promissory notes  465   541 
Mandatorily redeemable non-controlling interest  619   619 
Deferred income taxes  1,817   2,000 
Long term operating lease liabilities  1,142    
Other liabilities  
302
   
334
 
Total other liabilities  
10,655
   
10,096
 
Total liabilities  
39,231
   
44,841
 
Stockholders’ Equity:        
Preferred Stock, $0.001 par value; 100,000 shares authorized
   
   
 
Series B 5,700 shares authorized and 631 shares issued and outstanding as of March 31, 2020 and September 30, 2019, respectively
      
Series C 20,000 shares authorized and 20,000 shares issued and outstanding at March 31, 2020 and September 30, 2019, liquidation value of $12,867 and $12,541 at March 31, 2020 and September 30, 2019, respectively      
Common stock, $0.001 par value; 4,500,000 shares authorized, 867,652 issued and 847,652 outstanding as of March 31, 2020 and 863,812 issued and 843,812 outstanding as of September 30, 2019  1   1 
Paid-in capital  14,891   15,075 
Treasury stock, at cost, 20,000 shares  (240
)
  (240
)
Accumulated (deficit) earnings  
(1,015
)
  
42
 
Total stockholders’ equity  
13,637
   
14,878
 
Total liabilities and stockholders’ equity 
$
52,868
  
$
59,719
 

The accompanying notes are an integral part of these consolidated financial statements.

- 3 -


3

JANEL CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except share and per share data)
(Unaudited)

      Three months ended
June 30,
  Nine months ended
June 30,
 
      2017  2016  2017  2016 
                 
REVENUES                    
Global Logistics Services     $17,963,837  $15,425,092  $49,499,193  $53,935,789 
Manufacturing      2,283,041   2,080,361   6,444,205   2,792,667 
TOTAL REVENUES      20,246,878   17,505,453   55,943,398   56,728,456 
COST AND EXPENSES                    
Forwarding expenses      14,455,926   12,157,139   39,810,183   44,171,758 
Cost of revenues - manufacturing      989,313   961,587   2,888,458   1,266,878 
Selling, general and administrative      4,002,311   3,460,936   11,206,459   9,798,908 
Amortization of intangible assets      195,666   203,237   578,997   402,915 
TOTAL COSTS AND EXPENSES      19,643,216   16,782,899   54,484,097   55,640,459 
                     
INCOME FROM OPERATIONS      603,662   722,554   1,459,301   1,087,997 
OTHER ITEMS                    
Interest expense, net of interest income      (184,280)  (199,892)  (566,807)  (476,665)
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES      419,382   522,662   892,494   611,332 
Income taxes      (129,419)  (36,604)  (356,257)  (75,181)
NET INCOME FROM CONTINUING OPERATIONS      289,963   486,058   536,237   536,151 
Loss from discontinued operations, net of tax      -   (1,668)  -   (184,845)
NET INCOME      289,963   484,390   536,237   351,306 
Less: net income attributable to non-controlling interests      30,943   35,331   75,046   49,636 
NET INCOME ATTRIBUTABLE TO JANEL CORPORATION STOCKHOLDERS      259,020   449,059   461,191   301,670 
                     
Preferred stock dividends      (127,706)  (133,819)  (383,118)  (262,165)
NET INCOME AVAILABLE TO COMMON STOCKHOLDERS     $131,314  $315,240  $78,073  $39,505 
Income per share from continuing operations attributable to common stockholders:  Basic  $0.52  $0.85  $0.95  $0.93 
   Diluted  $0.42  $0.78  $0.77  $0.87 
                     
(Loss) per share from discontinued operations attributable to common stockholders:  Basic  $-  $-  $-  $(0.32)
   Diluted  $-  $-  $-  $(0.32)
                     
Net income (loss) per share attributable to common stockholders:  Basic  $0.24  $0.55  $0.14  $0.07 
   Diluted  $0.19  $0.51  $0.11  $0.06 
                     
Basic weighted average number of shares outstanding      553,951   573,951   567,309   573,951 
Fully-diluted weighted average number of shares outstanding      686,699   622,624   693,332   613,865 

  
Three Months Ended
March 31,
  
Six Months Ended
March 31,
 
  
2020
  
2019
  
2020
  
2019
 
Revenue 
$
19,121  
$
20,969  
$
38,942  
$
43,296 
Forwarding expenses and cost of revenues  
13,125
   
14,599
   
26,659
   
30,439
 
Gross profit  
5,996
   
6,370
   
12,283
   
12,857
 
Cost and Expenses:                
Selling, general and administrative  6,584   5,692   12,669   11,081 
Amortization of intangible assets  
243
   
236
   
486
   
444
 
Total Costs and Expenses  
6,827
   
5,928
   
13,155
   
11,525
 
(Loss) Income from Operations  
(831
)
  
442
   
(872
)
  
1,332
 
Other Items:                
Interest expense net of interest income  
(141
)
  
(198
)
  
(304
)
  
(360
)
(Loss) Income Before Income Taxes  
(972
)
  
244
   
(1,176
)
  
972
 
Income tax benefit (expense)  
35
   
(69
)
  
119
   
(253
)
Net (Loss) Income  (937)  175   (1,057)  719 
Preferred stock dividends  (175
)
  (148
)
  (326
)
  (270
)
Net (Loss) Income Available to Common Stockholders 
$
(1,112
)
 
$
27
  
$
(1,383
)
 
$
449
 
                 
Net (loss) Income per share                
Basic 
$
(1.08
)
 
$
0.21
  
$
(1.22
)
 
$
0.85
 
Diluted 
$
(1.08
)
 
$
0.18
  
$
(1.22
)
 
$
0.77
 
Net (loss) income per share attributable to common stockholders:                
Basic 
$
(1.29
)
 
$
0.04
  
$
(1.60
)
 
$
0.53
 
Diluted 
$
(1.29
)
 
$
0.03
  
$
(1.60
)
 
$
0.48
 
Weighted average number of shares outstanding:                
Basic  
865,985
   
847,784
   
865,630
   
847,621
 
Diluted  
865,985
   
931,960
   
865,630
   
934,137
 
The accompanying notes are an integral part of these consolidated financial statements.

- 4 -

JANEL CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY

(in thousands, except share and per share data)
(Unaudited)

  Common Stock  Preferred Stock  Paid-in  Accumulated  Treasury Stock     Non-
Controlling
  Total 
  Shares  $  Shares  $  Capital  Deficit  Shares  $  TOTAL  Interest  Equity 
                                  
Balance - September 30, 2016  573,951  $574   35,476  $36  $12,920,416  $(2,161,994)  -   -  $10,759,032  $1,001,226  $11,760,258 
Net income  -   -   -   -   -   461,191   -   -   461,191   75,046  $536,237 
Dividends to preferred stockholders  -   -   -   -   (383,118)  -   -   -   (383,118)  -  $(383,118)
Stock-based compensation  -   -   -   -   173,143   -   -   -   173,143   -  $173,143 
Treasury stock acquired  -   -   -   -   -   -   20,000   (240,000)  (240,000)  -  $(240,000)
Balance - June 30, 2017  573,951  $574   35,476  $36  $12,710,441  $(1,700,803)  20,000  $(240,000) $10,770,248  $1,076,272  $11,846,520 



  PREFERRED STOCK  COMMON STOCK  
PAID-IN
CAPITAL
  TREASURY STOCK  
ACCUMULATED
EARNINGS
(DEFICIT)
  
TOTAL
EQUITY
 
  SHARES  $  SHARES  $  $  SHARES  $  $  $ 
Balance - September 30, 2019  20,631  $   863,812  $1  $15,075   20,000  $(240) $42  $14,878 
Net Loss  
   
   
   
   
   
   
   
(1,057
)
  
(1,057
)
Dividends to preferred stockholders  
   
   
   
   
(326
)
  
   
   
   
(326
)
Stock-based compensation  
   
   
   
   
111
   
   
   
   
111
 
Stock option exercise  
   
   
3,840
   
   
31
   
   
   
   
31
 
Balance - March 31, 2020  20,631  $   867,652  $1  $14,891   20,000  $(240) $(1,015) $13,637 

  PREFERRED STOCK  COMMON STOCK  
PAID-IN
CAPITAL
  TREASURY STOCK  
ACCUMULATED
EARNINGS
(DEFICIT)
  
TOTAL
EQUITY
 
  SHARES  $  SHARES  $
  $  SHARES  $  $  $ 
Balance -September 30, 2018  21,271  $   837,951  $1  $15,872   20,000  $(240) $(606) $15,027 
Net Income  
   
   
   
   
   
   
   
719
   
719
 
Cumulative effect of change in accounting principle  
   
   
   
   
   
   
   
32
   
32
 
Dividends to preferred stockholders  
   
   
   
   
(270
)
  
   
   
   
(270
)
Vested restricted stock unissued  
   
   
   
   
(236
)
  
   
   
   
(236
)
Stock option exercise  
   
   
1,500
   
   
5
   
   
   
   
5
 
Stock-based compensation  
   
   
   
   
172
   
   
   
   
172
 
Balance - March 31, 2019  21,271  $   839,451  $1  $15,543   20,000  $(240) $145  $15,449 

The accompanying notes are an integral part of these consolidated financial statements.
JANEL CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(Unaudited)
  
Six Months Ended
March 31,
 
  
2020
  
2019
 
Cash Flows From Operating Activities:      
Net (loss) income 
$
(1,057
)
 
$
719 
Adjustments to reconcile net (loss) income to net cash provided by operating activities:        
Provision for uncollectible accounts  164   330 
Depreciation  92   152 
Deferred income tax  (183
)
  302 
Amortization of intangible assets  486   444 
Amortization of acquired inventory valuation  447   129 
Amortization of loan costs  14   5 
Stock-based compensation  149   236 
Changes in operating assets and liabilities, net of effects of acquisitions:        
Accounts receivable  7,510   (1,002
)
Inventory  (254
)
  (131
)
Prepaid expenses and other current assets  182   (134
)
Security deposits and other long term assets  (166
)
  (5
)
Accounts payable and accrued expenses  (6,166
)
  171 
Lease liability  5   - 
Other liabilities  
(14
)
  
56
 
Net cash provided by operating activities  1,209   1,272 
Cash Flows From Investing Activities:        
Acquisition of property and equipment, net of disposals  (131
)
  (253
)
Acquisitions  
(116
)
  
(1,935
)
Net cash used in investing activities  (247)  (2,188)
Cash Flows From Financing Activities:        
Repayments of term loan  (282
)
  (491
)
Proceeds from stock option exercise  31   5 
Line of credit, proceeds, net  (873
)
  2,234 
Repayment of subordinated promissory notes  
(73
)
  
(36
)
Net cash (used in) provided by financing activities  
(1,197
)
  
1,712
 
Net (decrease) increase in cash  (235
)
  796 
Cash at beginning of the period  
2,163
   
585
 
Cash at end of period 
$
1,928
  
$
1,381
 
         
Supplemental Disclosure of Cash Flow Information:        
Cash paid during the period for:
        
Interest 
$
309
  
$
360
 
Income taxes 
$
9
  
$
81
 
Non-cash operating activities: Operating lease right of use asset $1,900  $ 
Operating lease liabilities Non-cash investing activities:
 $1,917  $ — 
Contingent earn-out acquisition 
$
  
$
50
 
Subordinated Promissory notes of Honor 
$
  
$
456
 
Non-cash financing activities:
        
Dividends declared to preferred stockholders 
$
326
  
$
270
 
Vested restricted stock unissued 
$
  
$
236
 

The accompanying notes are an integral part of these consolidated financial statements.

- 5 -

JANEL CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

  Nine months ended June 30, 
  2017  2016 
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net Income $536,237  $351,306 
Plus (loss) from discontinued operations  -   184,845 
Adjustments to reconcile net income to net cash provided by (used in) operating activities:        
Bad debt expense  82,460   341 
Depreciation  85,291   62,592 
Deferred income tax  256,994   - 
Amortization of intangible assets  578,997   402,915 
Amortization of imputed interest  21,526   41,954 
Stock based compensation  173,143   91,492 
Changes in operating assets and liabilities:        
Accounts receivable  (753,754)  1,942,323 
Inventory  24,510   (49,397)
Prepaid expenses and sundry current assets  (87,655)  (64,279)
Accounts payable and accrued expenses  1,910,937   (1,924,522)
NET CASH PROVIDED BY OPERATING ACTIVITIES  2,828,686   1,039,570 
NET CASH USED IN DISCONTINUED OPERATIONS  -   (184,845)
   2,828,686   854,725 
CASH FLOWS FROM INVESTING ACTIVITIES:        
Acquisition of property and equipment  (136,118)  (307,550)
Cash acquired from acquisition  115,986   - 
Acquisition of subsidiary  (100,000)  (10,734,663)
NET CASH USED IN INVESTING ACTIVITIES  (120,132)  (11,042,213)
CASH FLOWS FROM FINANCING ACTIVITIES:        
Dividends paid  (11,250)  (11,250)
Proceeds (payments) from bank loans  (1,032,951)  5,479,229 
Proceeds from sale of preferred series C shares  -   4,352,663 
Repayment of notes payable - related party  (500,000)  - 
Treasury stock acquisition  (240,000)  - 
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES  (1,784,201)  9,820,642 
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS  924,353   (366,846)
CASH AND CASH EQUIVALENTS, beginning of the period  965,115   942,748 
CASH AND CASH EQUIVALENTS, end of period $1,889,468  $575,901 
         
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:        
Cash paid during the period for:        
Interest $545,281  $476,665 
Income taxes $145,470  $75,181 
Non-cash financing activities:        
Dividends declared to preferred stockholders $371,868  $262,165 
Acquisition of business:        
Intangible assets acquired $898,381  $12,102,838 

The accompanying notes are an integral part of these consolidated financial statements.

- 6 -

JANEL CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except share and per share data)
1.BASIS OF PRESENTATION, SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES

The accompanying interim unaudited consolidated financial statements have been prepared pursuant to the rules and regulations of Article 108 of Regulation S-X and the instructions to Form 10-Q of the Securities and Exchange Commission. As a result, certain information and footnote disclosures normally included in audited financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted. Janel Corporation (together with its subsidiaries, “the Company”(the “Company” or “Janel”) believes that the disclosures made are adequate to make the information presented not misleading. The consolidated financial statements reflect all adjustments which are, in the opinion of management, necessary to a fair statement of the results for the interim periods presented. The results of operations for the periods presented are not necessarily indicative of the results to be expected for a full fiscal year, or any other period. These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes included in the Company’s Form 10-K as filed with the Securities and Exchange CommissionCommission.
Business description
Janel is a holding company with subsidiaries in three business segments: Global Logistics Services, Manufacturing and Life Sciences. A management group at the holding company level (the “corporate group”) focuses on significant capital allocation decisions, corporate governance and supporting Janel’s subsidiaries where appropriate. Janel expects to grow through its subsidiaries’ organic growth and by completing acquisitions. We plan to either acquire businesses within our existing segments or about December 22, 2016.

2.ACQUISITIONS

INDCO,expand our portfolio into new strategic segments. Our acquisition strategy focuses on reasonably priced companies with strong and capable management teams, attractive existing business economics and stable and predictable earnings power.

Global Logistics Services
The Company’s Global Logistics Services segment is comprised of several wholly-owned subsidiaries, collectively known as “Janel Group.” Janel Group is a non-asset based, full-service provider of cargo transportation logistics management services, including freight forwarding via air-, ocean- and land-based carriers, customs brokerage services, warehousing and distribution services, and other value-added logistics services.
On November 20, 2018, we completed a business combination whereby we acquired the membership interest of Honor Worldwide Logistics, LLC (“Honor”), a global logistics services provider with two U.S. locations. See note 2.
On October 17, 2018, we completed a business combination whereby we acquired substantially all of the assets and certain liabilities of a global logistics services provider with one U.S. location. See note 2.
Manufacturing
The Company��s manufacturing segment is comprised of Indco, Inc. (“INDCO”Indco”)

General. On March 21, 2016,, a majority-owned subsidiary of the Company executedthat manufactures and closeddistributes mixing equipment and apparatus for specific applications within various industries. Indco’s customer base is comprised of small- to mid-sized businesses as well as other larger customers for which Indco fulfills repetitive production orders.

Life Sciences
The Company’s Life Sciences segment is comprised of Aves Labs, Inc. (“Aves”), Antibodies Incorporated (“Antibodies”), IgG, LLC (“IgG”) and PhosphoSolutions, LLC, which are wholly-owned subsidiaries of the Company.
The Company’s Life Sciences segment manufactures and distributes high-quality monoclonal and polyclonal antibodies, diagnostic reagents and other immunoreagents for biomedical research and provides antibody manufacturing for academic and industry research scientists. Our Life Sciences business also produces products for other life science companies on an original equipment manufacturer (“OEM”) basis.
Through Aves, the Company acquired the membership interests of a Stock Purchase Agreement (the “INDCO Purchase Agreement”small life sciences company on July 1, 2019 and the equity interests of PhosphoSolutions, LLC. (“Phospho”) foron September 6, 2019. Both acquisitions were completed primarily to expand our product offerings in Life Sciences. See note 2.
Basis of consolidation
The accompanying consolidated financial statements include the purchaseaccounts of the Company and its wholly-owned subsidiaries, as well as Indco, of which Janel owns 91.65%, with a non-controlling interest held by existing Indco management. The Indco non-controlling interest is mandatorily redeemable and is recorded as a liability. All intercompany transactions and balances have been eliminated in consolidation.
Uses of estimates in the preparation of financial statements
The preparation of financial statements in conformity with generally accepted accounting principles in the United States (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of financial statements, as well as the reported amounts of revenues and expenses during the reporting period. The most critical estimates made by the Company are those relating to accounts receivables valuation, the useful lives of long-term assets, accrual of cost related to ancillary services the Company provides and accrual of tax expense on an interim basis.
Cash
The Company maintains cash balances at various financial institutions. Accounts at each institution are insured by the Federal Deposit Insurance Corporation up to $250. The Company’s accounts at these institutions may, at times, exceed the federally insured limits. The Company has not experienced any losses in such accounts.
Accounts receivable and allowance for doubtful accounts receivable
Accounts receivable are recorded at the contractual amount. The Company records its allowance for doubtful accounts based upon its assessment of various factors. The Company considers historical collection experience, the age of the outstanding common stock (the “INDCO Shares”) of INDCO, which manufactures and distributes industrial mixing equipment. The INDCO Shares represent approximately 91.65%accounts receivable balances, credit quality of the beneficial ownershipCompany’s customers, any specific customer collection issues that have been identified, current economic conditions, and other factors that may affect the customers’ ability to pay. The Company writes off accounts receivable balances that have aged significantly once all collection efforts have been exhausted and the receivables are no longer deemed collectible from the customer. The allowance for doubtful accounts as of INDCO.March 31, 2020 and September 30, 2019 was $654 and $503, respectively.
Inventory
Inventory is valued at the lower of cost (using the first-in, first-out method) or net realizable value. The remaining 8.35% ownership was retained by existing INDCO management.

UnderCompany maintains an inventory valuation reserve to provide for slow moving and obsolete inventory, inventory not meeting quality control standards and inventory subject to expiration for its Antibodies business. The products of Antibodies require the termsinitial manufacture of multiple batches to determine if quality standards can consistently be met. In addition, the Company will produce larger batches of established products than current sales requirements due to economies of scale. The manufacturing process for these products, therefore, has and will continue to produce quantities in excess of forecasted usage. The Company values acquired manufactured antibody inventory based on a three-year forecast. Inventory quantities in excess of the INDCO Purchase Agreement,forecast are not valued due to uncertainty over salability. Amounts are charged to the purchase pricereserve when the Company scraps or disposes of inventory.

Property and equipment and depreciation policy
Property and equipment are recorded at cost. Property and equipment acquired in business combinations are initially recorded at fair value. Depreciation is provided for in amounts sufficient to amortize the INDCO shares was $11,000,000, subject to certain closing adjustments and customary indemnifications, representations and warranties. The purchase price was paid at closing in cash.

INDCO comprises the Manufacturing segmentcosts of the Company.

Purchase Price Allocation. In accordance with the acquisition method of accounting, the Company allocated the consideration to the net tangible and identifiable intangiblerelated assets based onover their estimated fair values, which were determined by an independent valuation performed by a third party,useful lives on the straight-line and accelerated methods for both financial reporting and income tax purposes.

Maintenance and repairs are recorded as of the effective acquisition date, March 1, 2016.

expenses when incurred.

Goodwill represents
The Company records as goodwill the excess of the purchase price over the fair value of the underlying net tangible and identifiable intangible assets.

The following table summarizesassets acquired in a business combination. Under current authoritative guidance, goodwill is not amortized but is tested for impairment annually (on September 30) as well as when an event or change in circumstance indicates impairment may have occurred. Goodwill is tested for impairment by comparing the fair values assignedvalue of the Company’s individual reporting units to their carrying amount to determine if there is potential goodwill impairment. If the fair value of the reporting unit is less than the carrying value, an impairment loss is recorded to the extent that the implied fair value of the goodwill of the reporting unit is less than its carrying value. If there is a material change in economic conditions, including as a result of continued disruption due to the coronavirus (COVID-19) pandemic, or other circumstances influencing the estimate of future cash flows or significantly affect the fair value of our reporting units, the Company could be required to recognize impairment charges in the future. There were no indicators of impairment of goodwill as of March 21, 2020 and September 30, 2019.

The fair value of our reporting units was in excess of carrying value and goodwill was not deemed to be impaired as of March 31, 2020 and September 30, 2019.
Intangibles and long-lived assets
Long-lived assets, acquiredincluding fixed assets and intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying value may not be recoverable. In reviewing for impairment, the carrying value of such assets is compared to the estimated undiscounted future cash flows expected from the use of the assets and their eventual disposition.
If such cash flows are not sufficient to support the asset’s recorded value, an impairment charge is recognized to reduce the carrying value of the long-lived asset to its estimated fair value. The determination of future cash flows, as well as the estimated fair value of long-lived assets, involves significant estimates on the part of management. If there is a material change in economic conditions, including as a result of continued disruption due to the coronavirus (COVID-19) pandemic, or other circumstances influencing the estimate of future cash flows or fair value, the Company could be required to recognize impairment charges in the future. There were no indicators of impairment of long-lived assets as of March 31, 2020 and September 30, 2019.
Business segment information
The Company operates in three reportable segments: Global Logistics Services, Manufacturing and Life Sciences. The Company’s Chief Executive Officer regularly reviews financial information at the reporting segment level in order to make decisions about resources to be allocated to the segments and to assess their performance.
Revenues and revenue recognition
Adoption of ASC Topic 606, “Revenue from Contracts with Customers”
On October 1, 2018, the Company adopted ASU 2014-09, Revenue from Contracts with Customers (“ASC Topic 606”), using the modified retrospective method. Results for reporting periods beginning on or after October 1, 2018 are presented under ASC Topic 606; however, prior period amounts are not adjusted and continue to be reported in accordance with the accounting standards in effect for those periods.
The Company recorded an increase to the opening balance of retained earnings of $32, net of tax, as of October 1, 2018 due to the cumulative impact of adoption of ASC Topic 606. The impact to revenue and associated cost for the six months ended March 31, 2019 was an increase of $218 and $177, respectively, as a result of applying ASC Topic 606.
Global Logistics Services
Revenue Recognition
Revenue is recognized upon transfer of control of promised services to customers. With respect to its Global Logistics Services segment, the Company has determined that in general each shipment transaction or service order constitutes a separate contract with the customer. When the Company provides multiple services to a customer, different contracts may be present for different services.
The Company typically satisfies its performance obligations as services are rendered at a point in time. A typical shipment would include services rendered at origin, such as pick-up and delivery to port, freight services from origin to destination port and destination services, such as customs clearance and final delivery. The Company measures the performance of its obligations as services are completed at a point in time during the life of a shipment, including services at origin, freight and destination. The Company fulfills nearly all of its performance obligations within a one to two-month period.
The Company evaluates whether amounts billed to customers should be reported as gross or net revenue. Generally, revenue is recorded on a gross basis when the Company is primarily responsible for fulfilling the promise to provide the services, when it has discretion in setting the prices for the services to the customers, and the Company has the ability to direct the use of the services provided by the third party. Revenue is recognized on a net basis when we do not have latitude in carrier selection or to establish rates with the carrier.
In the Global Logistics Services segment, the Company disaggregates its revenues by its four primary service categories: ocean import and export, freight forwarding, customs brokerage and air import and export. A summary of the Company’s revenues disaggregated by major service lines for the three and six months ended March 31, 2020 was as follows:
  
Three Months Ended
March 31,
  
Six Months Ended
March 31,
 
Service Type 
2020
  
2020
 
Ocean import and export 
$
5,880
  
$
11,737
 
Freight forwarding  
2,653
   
6,462
 
Customs brokerage  
3,111
   
5,305
 
Air import and export  
3,684
   
7,903
 
Total 
$
15,328
  
$
31,407
 

Manufacturing
Revenues from Indco are derived from the engineering, manufacture and delivery of specialty mixing equipment and accessories. Indco receives customer product orders via phone call, email, internet or fax. The pricing of each standard product sold is listed in Indco’s print and web-based catalog. Customer specific products are priced by quote. A sales order acknowledgement is sent to every customer for every order to confirm pricing and the specifications of the products ordered. The revenue is recognized at a point in time when the product is shipped to the customer.
Life Sciences
Revenues from the Life Sciences segment are derived from the sale of high-quality monoclonal and polyclonal antibodies, diagnostic reagents and diagnostic kits and other immunoreagents for biomedical research and antibody manufacturing. Revenues are recognized when products are shipped and risk of loss is transferred to the carrier(s) used.
Income (loss) per common share
Basic net income (loss) per share is computed by dividing net income (loss) for the period by the weighted average number of common shares outstanding, excluding unvested restricted stock, during the period. Diluted net income (loss) per share reflects the additional dilution from potential issuances of common stock, such as stock issuable pursuant to the exercise of stock options or warrants or the vesting of restricted stock units. The treasury stock method is used to calculate the potential dilutive effect of these common stock equivalents. Potentially dilutive shares are excluded from the computation of diluted net income (loss) per share when their effect is anti-dilutive.
Stock-based compensation to employees
Equity classified share-based awards
The Company recognizes compensation expense for stock-based payments granted based on the grant-date fair value estimated in accordance with ASC Topic 718, “Compensation-Stock Compensation.” For employee stock-based awards, we calculate the fair value of the award on the date of grant using the Black-Scholes method for stock options and the quoted price of our common stock for restricted shares; the expense is recognized over the service period for awards expected to vest.
Stock-based compensation to non-employees
Liability classified share-based awards
The Company maintains other share unit compensation grants for shares of Indco, the Company’s majority-owned subsidiary, which vest over a period of up to three years following their grant. The shares contain certain put features where the Company is either required or expects to settle vested awards on a cash basis.
These awards are classified as liability awards, measured at fair value at the date of grant and re-measured at fair value at each reporting date up to and including the settlement date. The determination of the fair value of the share units under these plans is described in note 10. The fair value of the awards is expensed over the respective vesting period of the individual awards with recognition of a corresponding liability. Changes in fair value after vesting are recognized through compensation expense. Compensation expense reflects estimates of the number of instruments expected to vest. The impact of forfeitures and fair value revisions, if any, are recognized in earnings such that the cumulative expense reflects the revisions, with a corresponding adjustment to the settlement liability. Liability-classified share unit liabilities due within 12 months of the reporting date are presented in trade and other payables while settlements due beyond 12 months of the reporting date are presented in non-current liabilities.
Non-employee share-based awards
In prior periods up to September 30, 2019, the Company accounted for stock-based compensation to non-employees and consultants in accordance with the provisions of ASC 505-50, “Equity-Based Payments to Non-employees.” Measurement of share-based payment transactions with non-employees are based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of share-based payment transactions is determined at the earlier of performance commitment date or performance completion date. The Company believes that the fair value of the stock-based award is more reliably measurable than the fair value of the services received. The fair value of the granted stock-based awards is remeasured at each reporting date and expense is recognized over the vesting period of the award.
In June 2018, the FASB issued ASU No. 2018-07, Compensation - Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. The guidance was issued to simplify the accounting for share-based transactions by expanding the scope of Topic 718 from only being applicable to share-based payments to employees to also include share-based payment transactions for acquiring goods and services from nonemployees. As a result, nonemployee share-based transactions will be measured by estimating the fair value of the equity instruments at the grant date, taking into consideration the probability of satisfying performance conditions.

The Company adopted ASU 2018-07 on October 1, 2019. The adoption of the standard did not have a material impact on our financial statements for the six months ended March 31, 2020.
Mandatorily Redeemable Non-Controlling Interests
The non-controlling interests that are reflected as mandatorily redeemable non-controlling interests in the consolidated financial statements consist of non-controlling interests related to the Indco acquisition whose owners have certain redemption rights that allow them to require the Company to purchase the non-controlling interests of those owners upon certain events outside the control of the Company, including upon the death of the holder. The Company is required to purchase 20% of the 8.35% mandatorily redeemable non-controlling interest at the option of the holder beginning on the third anniversary of the date of the Indco acquisition, which was March 21, 2019. As of March 31, 2020, the holder did not exercise the redemption rights.
On the date the Company acquires the controlling interest in a business combination, the fair value of the non-controlling interest is recorded in the long-term liabilities section of the consolidated balance sheet under the caption “Mandatorily redeemable non-controlling interest.” The mandatorily redeemable non-controlling interest is adjusted each reporting period, if required, to its then current redemption value, based on the predetermined formula defined in the respective agreement. The Company reflects any adjustment in the redemption value and any earnings attributable to the mandatorily redeemable non-controlling interest in its consolidated statements of operations by recording the adjustments and earnings to other income and expense in the caption “change in fair value of mandatorily redeemable non-controlling interest.”
Note receivable
On March 2, 2018, the Company issued a convertible promissory note in the amount of $125 with a potential non- related party acquisition target. The note bears interest on the outstanding principal amount at a rate of 8% per annum, and both principal and interest is payable on the maturity date of April 24, 2020. The convertible note, at the election of the Company, can be converted into common stock of the acquisition target. As of March 31, 2020, and September 30, 2019, amounts outstanding including accrued interest were $142 and $139, respectively. As of March 31, 2020, the Company is no longer pursuing this potential acquisition target.
Income taxes
The Company uses the asset and liability method of accounting for income taxes in accordance with ASC Topic 740, “Income Taxes.” Under this method, income tax expense is recognized for the amount of: (i) taxes payable or refundable for the current year and (ii) deferred tax consequences of temporary differences resulting from matters that have been recognized in an entity’s financial statements or tax returns. Deferred tax assets and liabilities assumed.

  Fair Value 
Cash $377,653 
Accounts receivable, net  620,632 
Inventory  372,212 
Prepaid expenses and other current assets  109,333 
Fixed assets  155,050 
Accounts payable and other liabilities  (1,690,202)
Note payable - related party  (129,258)
Customer relationships and other intangibles  7,700,000 
Goodwill  4,402,838 
Non-controlling interest  (918,258)
Purchase price $11,000,000 

- 7 -
are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income and the reversal of deferred tax liabilities during the period in which related temporary differences become deductible. The benefit of tax positions taken or expected to be taken in the Company’s income tax returns are recognized in the consolidated financial statements if such positions are more likely than not of being sustained.

W.J. Byrnes & Co. (“Byrnes”)

General.

Recent accounting pronouncements
Recently adopted accounting pronouncements
On AprilOctober 1, 2019, the Company adopted ASU No. 2016-02, Leases (“ASC 842” or “ASU 2016-02”) issued by the FASB in February 2016 which was subsequently supplemented by clarifying guidance intended to improve financial reporting of leasing transactions. The new lease accounting guidance requires lessees to recognize lease liabilities and right-of-use assets on the balance sheet for all leases with initial terms longer than 12 months and provides enhanced disclosures on key information of leasing arrangements. The guidance allows companies to apply the requirements retrospectively, either to all prior periods presented or through a cumulative adjustment in the year of adoption.
The Company adopted the new standards effective October 1, 2019 using the modified retrospective transition method. The Company elected to use the package of practical expedients which allowed the Company to (i) not reassess whether an arrangement contains a lease, (ii) carry forward its lease classification as operating or capital leases and (iii) not reassess its previously-recorded initial direct costs. For all existing operating leases as of October 1, 2019, the Company recorded operating lease right of use asset of $1,043 and corresponding lease liabilities of $1,060, with an offset to other liabilities of $17 to eliminate deferred rent on the consolidated balance sheets.
Operating lease expense is recognized on a straight-line basis over the lease term. At each balance sheet date, operating lease liabilities represent the present value of the future minimum payments related to non-cancelable periods.
Leases with an initial term of 12 months or less (short-term leases) are not recognized in the balance sheet, and the related lease payments are recognized as incurred over the lease term.
All significant lease arrangements after October 1, 2019 are recognized as right-of-use assets and lease liabilities at lease commencement. Right-of-use assets represent the Company’s right to use an underlying asset for the lease term, and lease liabilities represent its obligation to make lease payments arising from the lease. Right-of-use assets and liabilities are recognized at the commencement date based on the present value of the future lease payments using the Company’s incremental borrowing rate.
The adoption of the new lease accounting standard did not have a material impact on the Company’s results of operations or cash flows.
In June 2018, the FASB issued ASU 2018-07, Compensation - Stock Compensation, which expands the scope of Topic 718 to include all share-based payment transactions for acquiring goods and services from nonemployees. The amendments in this update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, with early adoption permitted. The Company’s current share-based payment awards to      non-employees consist only of grants made to its non-employee directors as compensation solely relates to each individual’s role as a non-employee director. As such, in accordance with ASC 718, the Company accounts for these share-based payment awards to its non-employee directors in the same manner as share-based payment awards for its employees. The Company adopted this standard on October 1, 2019, and the amendments in this guidance had no material effect on either the accounting for its share-based payment awards to its non-employee directors, or the Company’s consolidated financial statements.
Recently issued accounting pronouncements not yet adopted
In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement, which modifies the disclosure requirements on fair value measurements in Topic 820, Fair Value Measurement. This new accounting standard is effective for annual periods beginning after December 15, 2019. Early adoption is permitted. The Company is evaluating the effects that the adoption of this guidance will have on its disclosures.
In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other: Simplifying the Test for Goodwill Impairment, to simplify the subsequent measurement of goodwill by eliminating Step 2 from the goodwill impairment test. This new accounting standard is effective for annual periods beginning after December 15, 2019. Early adoption is permitted. The Company executedis evaluating the effects that the adoption of this guidance will have on its consolidated financial statements.
In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326), which replaces the incurred loss methodology previously employed to measure credit losses for most financial assets and closedrequires the use of a Stock Purchase Agreement (the “Byrnes Purchase Agreement”)forward-looking expected loss model. Current accounting delays the recognition of credit losses until it is probable a loss has been incurred, while the update will require financial assets to be measured at amortized costs less a reserve and equal to the net amount expected to be collected. This standard is effective for annual periods beginning after December 15, 2019, including interim periods within those fiscal years, with early adoption permitted. The Company is evaluating the effects that the adoption of this guidance will have on its consolidated financial statements.
Reclassifications
Prior year financial statement amounts are reclassified as necessary to conform to the current year presentation. These prior period reclassifications did not affect the Company’s net income, earnings per share, stockholders’ equity or working capital.
2.ACQUISITIONS
The Company completed four business acquisitions in the fiscal year ended September 30, 2019, with an aggregate purchase byprice of $6,768, net of cash acquired. The Company recorded an aggregate $2,067 in goodwill and $2,165 in other identifiable intangibles. The results of operations of the acquired businesses are included in Janel’s consolidated results of operations since the date of each acquisition. Supplemental pro forma information has not been provided as the acquisitions did not have a material impact on Janel’s consolidated results of operations, individually or in the aggregate.
Honor Worldwide Logistics, LLC
Through its wholly-owned subsidiary, Janel Group, the Company acquired the membership interests of 100%Honor on November 20, 2018 in a transaction pursuant to which Honor became a direct wholly-owned subsidiary of Janel Group and an indirect wholly-owned subsidiary of the outstanding common stock (the “Byrnes Shares”)Company. At closing, a subordinated promissory note in the aggregate amount of W.J. Byrnes & Co.,$456 was issued to a former member. The acquisition of Honor was funded with cash provided by normal operations along with a subordinated promissory note. Honor provides global logistics services provider with fivetwo U.S. locations.

Under the terms of the Byrnes Purchase Agreement, the purchase price for the Byrnes Shares was $100,000 in cash, paid at the closing, plus the assumption of Byrnes’ net liabilities, subject to certain closing adjustmentslocations and customary indemnifications, representations and warranties.

The Byrnes acquisition expands the domestic network of the Company’s Global Logistics Services segment.

Purchase Price Allocation. In accordance with The results of operations for Honor are reflected in the acquisition method of accounting,Global Logistics Services reporting segment.

PhosphoSolutions
Through Aves, the Company allocatedcompleted a business combination whereby we acquired Phospho on September 6, 2019.  The aggregate purchase price for Phospho was $4,043, net of $13 of cash received.  At closing, $4,000 was paid in cash and $56 was recorded in accrued expenses as preliminary tax gross up due to former owners.  Phospho is a manufacturer and distributor of monoclonal and polyclonal antibodies, principally used in neuroscience research. Phospho was founded in 2001 and is headquartered in Aurora, Colorado. The results of operations for Phospho are reflected in the Life Sciences reporting segment.  As of March 31, 2020, the Company paid $172 in tax gross up consideration to former owners and recorded an additional $116 of goodwill related to the net tangible and identifiable intangible assets based on their estimated fair values, which were determined by an independent valuation performed byPhospho acquistion.
Other Acquisitions
On October 17, 2018, we completed a third party, asbusiness combination whereby we acquired substantially all of the effective acquisition date, Aprilassets and certain liabilities of a global logistics services provider with one U.S. location. On July 1, 2017.

Goodwill represents2019, we acquired the excessmembership interests of a life sciences company to expand our product offerings in Life Sciences. These acquisitions were funded with cash provided by normal operations. The results of operations for these acquisitions are reported in our Global Logistics Services and Life Sciences segments. The aggregate purchase price for these acquisitions was $430. At closing, $50 was recorded in accrued expenses as a preliminary earnout consideration.

3.INVENTORY
Inventories consisted of the purchase price overfollowing:
  
March 31,
2020
  
September 30,
2019
 
Finished Goods 
$
2,627
  
$
2,988
 
Work-in-Process  
326
   
461
 
Raw Materials  
1,251
   
946
 
Less - Reserve for Inventory Valuation  
(26
)
  
(24
)
Inventory Net 
$
$ 4,178
  
$
4,371
 

4.PROPERTY AND EQUIPMENT
A summary of property and equipment and the fair valueestimated lives used in the computation of depreciation and amortization is as follows:
  
March 31,
2020
  
September 30,
2019
 
Life
 
Building and Improvements 
$
2,553
  
$
2,577
 15-30 Years 
Land and Improvements  
869
   
835
 Indefinite 
Furniture & Fixtures  
285
   
218
 3-7 Years 
Computer Equipment  
299
   
465
 3-5 Years 
Machinery & Equipment  1,151   973 3-15 Years 
Leasehold Improvements  
181
   
181
 Shorter of Lease Term or Asset Life 
   5,338   5,249   
Less: Accumulated Depreciation  
(1,346
)
  
(1,295
)
  
  
$
3,992
  
$
3,954
   

Depreciation expense for the underlying net tangiblesix months ended March 31, 2020 and identifiable intangible assets.

The following table summarizes the fair values assigned to the assets acquired2019 was $92 and liabilities assumed.

  Fair Value 
Cash $115,986 
Accounts receivable, net of allowance for doubtful accounts  298,803 
Customer relationships and other intangibles  240,000 
Goodwill  658,381 
Security deposits  15,275 
Note payable - bank  (224,998)
Accounts payable - trade  (891,169)
Accrued expenses and other current liabilities  (112,278)
Purchase price $100,000 

$152, respectively.
- 8 -

3.5.INTANGIBLE ASSETS

A summary of intangible assets and the estimated useful lives used in the computation of amortization is as follows:

  June 30,  September 30,   
  2017  2016  Life
Customer relationships $11,690,000  $11,450,000  15-20 years
Trademarks / names  1,770,000   1,770,000  20 years
Other  60,000   60,000  2-5 years
   13,520,000   13,280,000   
Less: accumulated amortization  (1,478,229)  (906,734)  
  $12,041,771  $12,373,266   

  
March 31,
2020
  
September 30,
2019
 
Life
 
Customer Relationships 
$
13,762
  
$
13,762
 15-20 Years 
Trademarks / Names  
2,251
   
2,251
 20 Years 
Other  
978
   
978
 2-5 Years 
   16,991   16,991   
Less: Accumulated Amortization  
(3,879
)
  
(3,393
)
  
  
$
13,112
  
$
13,598
   

Amortization expense for the six months ended March 31, 2020 and 2019 was $486 and $444, respectively.
6.4.GOODWILL
The Company’s goodwill carrying amounts relate to the acquisitions in the Global Logistics Services, Manufacturing and Life Sciences businesses.  As of March 31, 2020, the Company paid $172 in tax gross up consideration to former owners and recorded an additional $116 of goodwill related to the Phospho acquistion.
The composition of the goodwill balance at March 31, 2020 and September 30, 2019 was as follows:

  
March 31,
2020
  
September 30,
2019
 
Global Logistics Services 
$
5,655
  
$
5,655
 
Manufacturing  
5,046
   
5,046
 
Life Sciences  
2,940
   
2,824
 
  
$
13,641
  
$
13,525
 

7.NOTES PAYABLE - BANKS

Presidential Financial Corporation Borrowing Facility

(A)Santander Bank Facility
On March 27, 2014,October 17, 2017, the Janel Corporation and several of itsGroup subsidiaries within its Global Logistics Services segment (collectively the “Janel Group Borrowers”), with the Company as a guarantor, entered into a Loan and Security Agreement (the “Santander Loan Agreement”) with Presidential Financial CorporationSantander Bank, N.A. (“Presidential”Santander”) with respect to a revolving line of credit facility (the “Presidential“Santander Facility”).  As currently amended in March 2018, November 2018 and March 2020, the PresidentialSantander Facility currently provides that the Janel Group Borrowers can borrow up to $10,000,000,$17,000 limited to 85% of the Janel Group Borrowers’ aggregate outstanding eligible accounts receivable, subject to adjustment as set forth in the Santander Loan and Security Agreement. Interest will accrueaccrues on the Santander Facility at an annual rate equal to, five percent aboveat the greaterJanel Group Borrowers’ option, prime plus 0.50%, or LIBOR (30, 60 or 90 day) plus 2.25% subject to a LIBOR floor of (a) the prime rate of interest quoted in75 basis points. The Wall Street Journal from time to time, or (b) 3.25%. The Janel Group Borrowers’ obligations under the PresidentialSantander Facility are secured by all of the assets of the Janel Borrowers.Group Borrowers, while the Santander Loan Agreement contains customary terms and covenants. The Loan Security Agreement requires, among other things, thatSantander Facility matures on October 17, 2022, unless earlier terminated or renewed.  As a result of its terms, the Company,Santander Facility is classified as a current liability on a monthly basis, maintain a “minimum fixed charge covenant ratio” and “tangible net worth,” both as defined. The Presidential Facility will expire onthe consolidated balance sheet.
At March 27, 2018, subject to earlier termination as provided in the Loan and Security Agreement, unless renewed.

As of June 30, 2017, there were31, 2020, outstanding borrowings of $6,442,500 under the PresidentialSantander Facility were $7,533, representing 90.7%82.33% of the $7,104,942 available thereunder.amount thereunder, and interest was accruing at an effective interest rate of 3.26%. The Janel Group Borrowers arewere in compliance with the covenants defined in the Santander Loan Agreement at March 31, 2020 and Security Agreement.

First Merchants Bank Borrowing Facility

September 30, 2019.

(B)First Merchants Bank Credit Facility
On March 21, 2016, INDCO executedas amended in August 2019, Indco entered into a Credit Agreement (the “First Merchants Credit Agreement”) with First Merchants Bank (“First Merchants”) with respect to a $6,000,000$5,500 term loan and $1,500,000$1,000 (limited to the borrowing base and reserves) revolving loan(together, (together, the “First Merchants Facility”). Interest will accrueaccrues on the term loan at an annual rate equal to the one-month LIBOR plus either 3.75%2.75% (if INDCO’s cash flow leverageIndco’s total funded debt to EBITDA ratio is less than 2:1), or equal3.5% (if Indco’s total funded debt to 2:1) or 4.75% (if INDCO’s cash flow leverageEBITDA ratio is greater than or equal to 2:1). Interest accrues on the revolving loan at an annual rate equal to the one-month LIBOR plus 2.75%. INDCO’sIndco’s obligations under theFirst Merchants Facilityare secured by all of INDCO’sIndco’s assets and are guaranteed by the Company.Company, and the Company’s guarantee of Indco’s obligations is secured by a pledge of the Company’s Indco shares. The First Merchants Credit Agreement requires, among other things, that INDCO, on a monthly basis, not exceed a “maximum total funded debt to EBITDA ratio”contains customary terms and maintain a “minimum fixed charge covenant ratio,” both as defined.covenants. TheFirst Merchants Facilityrequires monthly payments until the expiration date will expire on the fifth anniversary of the loan. The loan is subjectAugust 30, 2024 (subject to earlier termination as provided in the Credit Agreement,Agreement) unless renewed.

As of June 30, 2017,March 31, 2020, there were no outstanding borrowings under the revolving loan and there were outstanding$4,931 of borrowings of $4,533,994 under the term loan. INDCO isloan, with interest accruing on the term loan at an effective interest rate of 5.08%.
The Company was in compliance with the covenants defined in the First Merchants Credit Agreement.

Agreement at March 31, 2020 and September 30, 2019.
  
March 31,
2020
  
September 30,
2019
 
Long Term Debt*
 
$
4,931
  
$
5,455
 
Less Current Portion  
(786
)
  
(786
)
  
$
4,145
  
$
4,669
 


*5.LONG-TERM DEBT – RELATED PARTY
Note: Long Term Debt is due in monthly installments of $71 plus monthly interest, at LIBOR plus 3.75% to 4.75% per annum. The note is collateralized by all of Indco’s assets and guaranteed by Janel.

Long-term debt - related party consists

16

(C)- 9 -First Northern Bank of Dixon

6.STOCKHOLDERS’ EQUITY

On October 1, 2016,June 21, 2018, AB Merger Sub, Inc., a wholly-owned, indirect subsidiary of the Company, entered into a Business Loan Agreement (the “First Northern Loan Agreement”) with First Northern Bank of Dixon (“First Northern”), with respect to a $2,025 First Northern Term Loan (the “First Northern Term Loan”). The proceeds of the First Northern Term Loan were used to fund a portion of the merger consideration to acquire Antibodies.  Interest was to accrue on the First Northern Term Loan at an annual rate based on the five-year Treasury constant maturity (index) plus 2.50% (margin) for years one through five then adjusted and fixed for years six through ten using the same index and margin. The borrower’s and the Company’s obligations to First Northern under the First Northern Loan Agreement are secured by certain real property owned by Antibodies as of the closing of the Antibodies merger. The First Northern Loan Agreement contains customary terms and covenants and matures on June 14, 2028 (subject to earlier termination).

On November 18, 2019, Antibodies modified and refinanced its existing credit facilities with First Northern Bank. The existing First Northern Term Loan was increased to $2,235, the initial interest rate decreased to 4.18%, and the maturity date was extended to November 14, 2029, with all other terms, covenants and conditions substantially unchanged. The existing revolving credit facility was expanded to $500, the interest rate decreased to 6.0%, and the maturity date was extended to October 1, 2020, with all other terms, covenants and conditions substantially unchanged. Additionally, Antibodies entered into a new business loan agreement (“Solar Loan”) which provided for a $125 term loan in connection with a potential expansion of solar generation capacity on the Antibodies property. The initial interest rate on the facility is 4.43%, subject to grantadjustment in five years.
As of March 31, 2020, there were no outstanding borrowings under the revolving credit facility and $2,217 of borrowings under the term loan.
  
March 31,
2020
  
September 30,
2019
 
Long Term Debt*
 
$
2,217
  
$
1,975
 
Less Current Portion  
(52
)
  
(42
)
  
$
$2,165
  
$
1,933
 


*
Note: Long Term Debt is due in monthly principal and interest installments of $12 plus monthly interest, at an effective interest rate of 4.18% as of March 31, 2020 and 5.28% as of September, 2019, per annum. The note is collateralized by real property owned by Antibodies and guaranteed by Janel.
The Company was in compliance with the covenants defined in the First Northern Loan Agreement at March 31, 2020 and September 30, 2019.
8.SUBORDINATED PROMISSORY NOTES
On June 22, 2018, in connection with the Antibodies acquisition, AB HoldCo, Inc. (“AB HoldCo”), a consultant optionswholly-owned subsidiary of the Company, entered into two subordinated promissory notes (“AB HoldCo Subordinated Promissory Notes”) with certain former shareholders of Antibodies. As the result of the merger of AB HoldCo into Antibodies, Antibodies became the obligor under the AB HoldCo Subordinated Promissory Notes.  Both of the AB HoldCo Subordinated Promissory Notes are guaranteed by the Company and are subordinate to purchase 6,053the terms of any credit agreement, loan agreement, indenture, promissory note, guaranty or other debt instrument pursuant to which the obligor  or any affiliate of the obligor  incurs, borrows, extends, guarantees, renews or refinances any indebtedness for borrowed money or other extensions of credit with any federal or state bank or other institutional lender and are unsecured. Each of the AB HoldCo Subordinated Promissory Notes has a 4% annual interest rate payable in arrears on the last business day of each calendar quarter, commencing on September 30, 2018, and the full outstanding principal balance and accrued, unpaid interest is due on June 22, 2021. Both notes are subject to prepayment in whole or in part, without premium or penalty, of the outstanding principal amount of the notes, together with all accrued interest on such principal amount up to the date of prepayment.  Any prepayment shall be applied first to accrued but unpaid interest, and then to outstanding principal. As of March 31, 2020, and September 30, 2019, amounts outstanding under the two AB HoldCo Subordinated Promissory Notes was $344 and is included in the long term portion of subordinated promissory notes.
On November 20, 2018, in connection with the Honor acquisition, Janel Group, a wholly-owned subsidiary of the Company, entered into a subordinated promissory note (“Janel Group Subordinated Promissory Note”) with a former owner of Honor. The Janel Group Subordinated Promissory Note is guaranteed by the Company. The Janel Group Subordinated Promissory Note is subordinate to and junior in right of payment for principal interest premiums and other amounts payable to the Santander Bank Facility and the First Merchants Bank Credit Facility. The Janel Group Subordinated Promissory Note, has a 6.75% annual interest rate, payable in twelve equal consecutive quarterly installments of principal and interest, on the last day of January, April, July and October beginning in January 2019, and shall be due and payable each in the amount of $42. The outstanding principal and accrued and unpaid interest are payable in a single payment on the three-year anniversary date of November 20, 2021. The note is subject to prepayment in whole or in part, without premium or penalty, of the outstanding principal amount of the notes, together with all accrued but unpaid interest on such principal amount up to the date of prepayment.  As of March 31, 2020, and September 30, 2019, the amounts outstanding under the Janel Group Subordinated Promissory Note was $276 and $349, respectively.

  March 31,
2020
  September 30,
2019
 
Long term portion of subordinated promissory notes
 
$
121
  
$
197
 
Current portion of subordinated promissory note
  
155
   
152
 
 
 
$
276
  
$
349
 

9.STOCKHOLDERS�� EQUITY
Janel is authorized to issue 4,500,000 shares of common stock, ($25,000 worth of stock based on the September 30, 2016 closing price of $4.13) at an exercise price of $4.13 per share. The options are exercisable in three installments on each of October 1, 2017, 2018 and 2019.

On March 31, 2017,par value $0.001. In addition, the Company acquired 20,000is authorized to issue 100,000 shares of its commonpreferred stock, for an aggregatepar value $0.001. The preferred stock is issuable in series with such voting rights, if any, designations, powers, preferences and other rights and such qualifications, limitations and restrictions as may be determined by the Company’s board of $240,000. This amount was paid in April 2017.

On May 12, 2017,directors or a duly authorized committee thereof, without stockholder approval. The board of directors may fix the two executive officers were granted an aggregatenumber of 11,121 options to purchaseshares constituting each series and increase or decrease the number of shares of any series.

(A)Preferred Stock
Series B Convertible Preferred Stock
Shares of the Company’s Series B Convertible Preferred Stock (the “Series B Stock”) are convertible into shares of the Company’s $0.001 par value common stock under the Company’s 2013 Non-Qualified Stock Option Plan. The options are exercisableat any time on a one-share (of Series B Stock) for ten-shares (of common stock) basis. On September 6, 2019, a period of ten years at an exercise price of $8.01 per share. Eight-thousand options were immediately exercisable, and 3,121 options are exercisable in three equal annual installments commencing on the first anniversaryholder of the grant date.

On May 12, 2017, two employees were granted an aggregateSeries B Stock converted 640 shares of 10,000 options to purchaseSeries B Stock into 6,400 shares of the Company’s common stock underCommon Stock.

Series C Cumulative Preferred Stock
Shares of the Company’s 2013 Non-QualifiedSeries C Cumulative Preferred Stock Option Plan. The options(the “Series C Stock”) are exercisable forentitled to receive annual dividends at a periodrate of ten years at an exercise5% per annum of the original issuance price of $8.01 per share.$10, when and if declared by the Company’s board of directors, with such rate increased by 1% annually beginning on January 1, 2019.  Such rate is to increase on each January 1 thereafter for four years to a maximum rate of 9%. The shares are exercisable in threedividend rate of the Series C Stock as of March 31, 2020 was 7%. In the event of liquidation, holders of the Series C Stock shall be paid an amount equal annual installments commencingto the original issuance price, plus any accrued but unpaid dividends thereon. Shares of the Series C Stock may be redeemed by the Company at any time upon notice and payment of the original issuance price, plus any accrued but unpaid dividends thereon. The liquidation value of the Series C Stock was $12,867 as of March 31, 2020.
For the six months ended March 31, 2020, the Company declared dividends on the first anniversarySeries C Stock of $326. As of March 31, 2020, the grant date.

Company had accrued dividends of $1,366.

(B)Equity Incentive Plan
On May 12, 2017, the Company adopted the Company’s 2017 Equity Incentive Plan (the “Plan”) pursuant to which (i) incentive stock options, (ii)was amended on May 8, 2018 (as amended, the “2017 Plan”).  Under the 2017 Plan, non-statutory stock options, (iii) restricted stock awards and (iv) stock appreciation rights with respect to shares of the Company’s common stock may be granted to directors, officers, employees of and consultants to the Company. Participants and all terms of any awards under the Plan are at the discretion of the Company’s BoardCompensation Committee of Directors in its role as the Compensation Committee.

board of directors.

10.STOCK-BASED COMPENSATION
On May 12, 2017, a non-executive director was granted an aggregateOctober 30, 2013, the board of 6,524directors of the Company adopted the Company’s 2013 Non-Qualified Stock Option Plan (the “2013 Option Plan”) providing for options to purchase up to 100,000 shares of the Company’s common stock underfor issuance to directors, officers, employees of and consultants to the Plan. Company and its subsidiaries.
Total stock-based compensation for the six months ended March 31, 2020 and 2019 amounted to $149 and $236, respectively, and was included in selling, general and administrative expense in the Company’s statements of operations.
(A)Stock Options
The Company uses the Black-Scholes option pricing model to estimate the fair value of our share-based awards. In applying this model, we use the following assumptions:
Risk-free interest rate - We determine the risk-free interest rate by using a weighted average assumption equivalent to the expected term based on the U.S. Treasury constant maturity rate.
Expected term - We estimate the expected term of our options on the average of the vesting date and term of the option.
Expected volatility - We estimate expected volatility using daily historical trading data of a peer group.
Dividend yield - We have never paid dividends on our common stock and currently have no plans to do so; therefore, no dividend yield is applied.
The fair values of our employee option awards were estimated using the assumptions below, which yielded the following weighted average grant date fair values for the periods presented:
Six Months Ended
March 31,
2020
Risk-free Interest Rate1.59%

Expected Option Term in Years5.5-6.5
Expected Volatility101.2% - 101.7%

Dividend Yield0%

Weighted Average Grant Date Fair Value
$6.97 - $7.33

Options for Employees
  
Number of
Options
  
Weighted
Average Exercise
Price
  
Weighted
Average
Remaining
Contractual
Term (in years)
  
Aggregate
Intrinsic Value
(in thousands)
 
Outstanding Balance at September 30, 2019  
110,837
  
$
5.05
   
5.98
  
$
438.06
 
Granted  
7,500
  
$
9.00
   
9.75
  
$
 
Exercised  
(3,841
)
 
$
8.17
   
  
$
 
Outstanding Balance at March 31, 2020  
114,496
  
$
5.21
   
5.67
  
$
290.88
 
Exercisable on March 31, 2020  
96,792
  
$
4.62
   
5.15
  
$
290.88
 

The aggregate intrinsic value in the above table was calculated as the difference between the closing price of the Company’s common stock at March 31, 2020 of $7.50 per share and the exercise price of the stock options that had strike prices below such closing price.
As of March 31, 2020, there was approximately $51 of total unrecognized compensation expense related to the unvested employee stock options which is expected to be recognized over a weighted average period of less than one year.
Options for Non-Employees
There were no non-employee options awarded during the six-month period ended March 31, 2020. During the six-month period ended March 31, 2020, 15,000 non-employee options were forfeited.
  
Number of
Options
  
Weighted
Average Exercise
Price
  
Weighted
Average
Remaining
Contractual
Term (in years)
  
Aggregate
Intrinsic Value
(in thousands)
 
Outstanding Balance at September 30, 2019  
51,053
  
$
7.58
   
7.80
  
$
72.68
 
Forfeited  (15,000
)
 
$
8.04
   
  
$
 
Outstanding Balance at March 31, 2020  
36,053
  
$
7.38
   
7.26
  
$
20.40
 
Exercisable on March 31, 2020  
6,053
  
$
4.13
   
6.50
  
$
20.40
 

The aggregate intrinsic value in the above table was calculated as the difference between the closing price of our common stock at March 31, 2020, of $7.50 per share and the exercise price of the stock options that had strike prices below such closing price.
As of March 31, 2020, there was approximately $32 of total unrecognized compensation expense related to the unvested stock options, which is expected to be recognized over a weighted average period of less than one year.
Liability classified share-based awards
Additionally, during the six months ended March 31, 2020, 6,880 options were granted with respect to Indco’s common stock. The Company uses the Black-Scholes option pricing model to estimate the fair value of Indco’s share-based awards. In applying this model, the Company used the following assumptions:
Six Months Ended
March 31,
2020
Risk-free Interest Rate1.59%

Expected Option Term in Years5.5 - 6.5
Expected Volatility101.2% - 101.7%

Dividend Yield0%

Weighted Average Grant Date Fair Value

$8.59 - $9.03

  
Number of
Options
  
Weighted
Average Exercise
Price
  
Weighted
Average
Remaining
Contractual
Term (in years)
  
Aggregate
Intrinsic Value
(in thousands)
 
Outstanding Balance at September 30, 2019  
32,133
  
$
8.85
   
7.34
  
$
85.45
 
Granted  6,880  
$
11.08
   
9.75
  
$
 
Outstanding Balance at March 31, 2020  
39,013
  
$
9.24
   
7.31
  
$
85.45
 
Exercisable on March 31, 2020  
23,343
  
$
7.98
   
6.49
  
$
85.45
 

The aggregate intrinsic value in the above table was calculated as the difference between the valuation price of Indco’s common stock at March 31, 2020 of $11.08 per share and the exercise price of the stock options that had strike prices below such closing price.
The liability classified awards were measured at fair value at each reporting date until the final measurement date, which was the date of completion of services required to earn the option. The accrued compensation cost related to these options was approximately $302 and $172 as of March 31, 2020 and September 30, 2019, respectively, and is included in other liabilities in the consolidated financial statement.  The cost associated with the options issued on each grant date is being recognized ratably over the period of service required to earn each tranche of options.
Upon vesting, the options continue to be accounted for as a liability in accordance with ASC 480-10-25-8 and are measured in accordance with ASC 480-10-35 at every reporting period until the options are settled. Changes in the fair value of the vested options are recognized in earnings in the consolidated financial statements.
The options are exercisableclassified as liabilities, and the underlying shares of Indco’s common stock also contain put options which result in their classification as mandatorily redeemable securities. While their redemption does not occur on a fixed date, there is an unconditional obligation for the Company to repurchase the shares upon death, which is certain to occur at some point in time.
As of March 31, 2020, there was approximately $66 of total unrecognized compensation expense related to the unvested Indco stock options. This expense is expected to be recognized over a weighted average period of ten years at an exercise priceless than one year.
(B)Restricted Stock
During the six months ended March 31, 2020, there were no shares of $8.01 per share. The shares are exercisable in three equal annual installments commencing on October 1,restricted stock granted. Under the 2017 Plan, each grant of restricted stock vests over a three-year period, and the subsequent anniversaries thereafter.

On May 12, 2017,cost to the Company granted 15,000 and 10,000recipient is zero. Restricted Stock Awards tostock compensation expense, which is a non-executive director and a consultant, respectively,non-cash item, is being recognized in the Company’s financial statements over the vesting period of each restricted stock grant.

The following table summarizes the status of our employee unvested restricted stock under the Plan. Each grant vests2017 Plan for the six months ended March 31, 2020:
  
Restricted Stock
(in thousands)
  
Weighted Average
Grant Date Fair Value
  
Weighted Average
 Remaining
Contractual Term
(in years)
 
Unvested at September 30, 2019  
5,000
  
$
8.01
   
0.61
 
Vested  
  
$
   
 
Unvested at March 31, 2020  
5,000
  
$
8.01
   
0.11
 

As of March 31, 2020, there was approximately $2 of total unrecognized compensation cost related to unvested employee restricted stock. The cost is expected to be recognized over a weighted-average period of approximately 0.11 years.
The following table summarizes the status of our non-employee unvested restricted stock under the 2017 Plan for the six months ended March 31, 2020:
  
Restricted Stock
(in thousands)
  
Weighted Average
Grant Date Fair Value
  
Weighted Average
Remaining
Contractual Term
(in years)
 
Unvested at September 30, 2019  
26,667
  
$
8.04
   
0.88
 
Vested  
  
$
   
 
Unvested at March 31, 2020  
26,667
  
$
8.04
   
0.38
 

As of March 31, 2020, there was approximately $30 of unrecognized compensation cost related to non-employee unvested restricted stock. The cost is expected to be recognized over a weighted-average period of approximately 0.38 years.
As of March 31, 2020, included in three equal annual installments commencing on October 1, 2017.

accrued expenses and other current liabilities was $159 which represents 18,333 shares of restricted stock that vested but were not issued.
11.7.INCOME PER COMMON SHARE
The following table provides a reconciliation of the basic and diluted income (loss) per share (“EPS”) computations for the three and six months ended March 31, 2020 and 2019 (in thousands, except share and per share data):
  
For the Three Months Ended
March 31,
  
For the Six Months Ended
March 31,
 
  
2020
  
2019
  
2020
  
2019
 
Income:            
Net income (loss) 
$
(937
)
 
$
175  
$
(1,057
)
 
$
719 
Preferred stock dividends  
(175
)
  
(148
)
  
(326
)
  
(270
)
Net Income (loss) available to common stockholders 
$
(1,112
)
 
$
27
  
$
(1,383
)
 
$
449
 
                 
Common Shares:                
Basic - weighted average common shares  865,985   847,784   865,630   847,621 
Effect of dilutive securities:                
Stock options     51,097      54,644 
Restricted stock     20,369      19,162 
Convertible preferred stock  
   
12,710
   
   
12,710
 
Diluted - weighted average common stock 
$
865,985
  
$
931,960
  
$
865,630
  
$
934,137
 
                 
Income per Common Share:                
Basic -                
Net income (loss) 
$
(1.08
)
 
$
0.21  
$
(1.22
)
 
$
0.85 
Preferred stock dividends  
(0.21
)
  
(0.17
)
  
(0.38
)
  
(0.32
)
Net Income (loss) available to common stockholders 
$
(1.29
)
 
$
0.04
  
$
(1.60
)
 
$
0.53
 
                 
Diluted -                
Net income (loss) 
$
(1.08
)
 
$
0.18  
$
(1.22
)
 
$
0.77 
Preferred stock dividends  
(0.21
)
  
(0.15
)
  
(0.38
)
  
(0.29
)
Net income (loss) available to common stockholders 
$
(1.29
)
 
$
0.03
  
$
(1.60
)
 
$
0.48
 

The computation for the diluted number of shares excludes unvested restricted stock, unexercised stock options and unexercised warrants that are anti-dilutive. There were no anti-dilutive shares for the six-month periods ended March 31, 2020.
Potentially dilutive securities as of March 31, 2020 and 2019 were as follows:
  
March 31,
 
  
2020
  
2019
 
Employee Stock Options  
114,496
   
118,798
 
Non-employee Stock Options  
36,053
   
51,053
 
Employee Restricted Stock  
5,000
   
5,000
 
Non-employee Restricted Stock  
26,667
   
26,667
 
Convertible Preferred Stock  
6,310
   
12,710
 
   
188,526
   
214,228
 

12.INCOME TAXES
The Company’s estimated fiscal 2020 and 2019 blended U.S. federal statutory corporate income tax rate of 10.1% and 25.2%, respectively, were applied in the computation of the Company’s income tax provision for the six months ended March 31, 2020 and 2019.

The reconciliation of income tax computed at the Federal statutory rate to the benefit (provision) for income taxes for the six months ended March 31, 2020 is as follows:

  
March 31,
2020
  
March 31,
2019
 
Federal taxes at statutory rates 
$
247
  
$
(204
)
Permanent differences  
(28
)
  
(13
)
Other  
(63
)
  
-
 
State and local taxes  
(37
)
  
(36
)
Income tax benefit (expense) 
$
119
  
$
(253
)

13.BUSINESS SEGMENT INFORMATION

As of June 30, 2017,discussed above in note 1, the Company operates in twothree reportable segments,segments: 1) Global Logistics Services, 2) Manufacturing and Manufacturing,3) Life Sciences, supported by a corporate group which conducts activities that are non-segment specific. The following table presentstables present selected financial information about the Company’s reportable segments for the three and ninesix months ended March 31, 2020:
For the three months ended
March 31, 2020
 
Consolidated
  
Global Logistics
Services
  
Manufacturing
  
Life Sciences
  
Corporate
 
Revenue 
$
19,121
  
$
15,328
  
$
2,056
  
$
1,737
  
$
 
Forwarding expenses and cost of revenues  
13,125
   
11,615
   
908
   
602
   
 
Gross profit  
5,996
   
3,713
   
1,148
   
1,135
   
 
Selling, general and administrative  
6,584
   
3,952
   
701
   
1,071
   
860
 
Amortization of intangible assets  
243
   
   
   
   
243
 
Operating (loss) income  
(831
)
  
(239
)
  
447
   
64
   
(1,103
)
Interest expense (income) net  
141
   
54
   
66
   
24
   
(3
)
Identifiable assets  
55,868
   
14,012
   
2,425
   
9,650
   
26,781
 
Capital expenditures  
34
   
17
   
   
17
   
 

For the six months ended
March 31, 2020
 
Consolidated
  
Global Logistics
Services
  
Manufacturing
  
Life Sciences
  
Corporate
 
Revenue 
$
38,942
  
$
31,407
  
$
3,926
  
$
3,609
  
$
 
Forwarding expenses and cost of revenues  
26,659
   
23,702
   
1,753
   
1,204
   
 
Gross profit  
12,283
   
7,705
   
2,173
   
2,405
   
 
Selling, general and administrative  
12,669
   
7,590
   
1,383
   
2,051
   
1,645
 
Amortization of intangible assets  
486
   
   
   
   
486
 
Operating (loss) income  
(872
)
  
115
   
790
   
354
   
(2,131
)
Interest expense (income) net  
304
   
120
   
138
   
51
   
(5
)
Identifiable assets  
52,868
   
14,012
   
2,425
   
9,650
   
26,781
 
Capital expenditures  
131
   
64
   
23
   
44
   
 

The following tables present selected financial information about the Company’s reportable segments for the three and six months ended March 31, 2019:
For the three months ended
March 31, 2019
 
Consolidated
  
Global Logistics
Services
  
Manufacturing
  
Life Sciences
  
Corporate
 
Revenue 
$
20,969
  
$
16,865
  
$
2,452
  
$
1,652
  
$
 
Forwarding expenses and cost of revenues  
14,599
   
12,957
   
1,077
   
565
   
 
Gross profit  
6,370
   
3,908
   
1,375
   
1,087
   
 
Selling, general and administrative  
5,692
   
3,468
   
759
   
724
   
741
 
Amortization of intangible assets  
236
   
   
   
   
236
 
Operating income (loss)  
442
   
440
   
616
   
363
   
(977
)
Interest expense (income) net  
198
   
127
   
36
   
37
   
(2
)
Identifiable assets  
52,868
   
14,012
   
2,425
   
9,650
   
26,781
 
Capital expenditures  
71
   
2
  

   
69
   
 

For the six months ended
March 31, 2019
 
Consolidated
  
Global Logistics
Services
  
Manufacturing
  
Life Sciences
  
Corporate
 
Revenue 
$
43,296
  
$
35,670
  
$
4,533
  
$
3,093
  
$
 
Forwarding expenses and cost of revenues  
30,439
   
27,375
   
2,010
   
1,054
   
 
Gross profit  
12,857
   
8,295
   
2,523
   
2,039
   
 
Selling, general and administrative  
11,081
   
6,828
   
1,467
   
1,431
   
1,355
 
Amortization of intangible assets  
444
   
   
   
   
444
 
Operating income (loss)  
1,332
   
1,467
   
1,056
   
608
   
(1,799
)
Interest expense (income) net  
360
   
225
   
76
   
64
   
(5
)
Identifiable assets  
55,348
   
20,825
   
2,418
   
6,672
   
25,433
 
Capital expenditures  
253
   
16
   
41
   
196
   
 

14.RISKS AND UNCERTAINTIES
(A)Currency Risks
The nature of Janel’s operations requires it to deal with currencies other than the U.S. Dollar. As a result, the Company is exposed to the inherent risks of international currency markets and governmental interference. A number of countries where Janel maintains offices or agent relationships have currency control regulations. The Company attempts to compensate for these exposures by accelerating international currency settlements among those agents.
(B)Concentration of Credit Risk
The Company’s assets that are exposed to concentrations of credit risk consist primarily of cash and receivables from customers. The Company places its cash with financial institutions that have high credit ratings. The receivables from clients are spread over many customers. The Company maintains an allowance for uncollectible accounts receivable based on expected collectability and performs ongoing credit evaluations of its customers’ financial condition. We have experienced heightened customer credit risk as a result of the negative impact to customers’ financial condition, employment levels and consumer confidence arising from economic disruptions related to the COVID-19 pandemic, and expect that our risk in this area will remain high as long as the disruptions persist.
(C)Legal Proceedings
Janel is occasionally subject to claims and lawsuits which typically arise in the normal course of business. While the outcome of these claims cannot be predicted with certainty, management does not believe that the outcome of any of these legal matters will have a material adverse effect on the Company’s business, results of operations, financial condition or cash flows.
In December 2017, Janel Group received a Notice of Copyright Infringement letter from counsel for Warren Communications News, Inc. (“Warren”), the publisher of the International Trade Today (“ITT”) newsletter. The letter alleges that Janel Group infringed upon Warren’s registered copyrights in its ITT newsletter (the “Warren Matter”). As of March 31, 2020, the Company had a liability for settlement costs related to the Warren Matter, which is included in accrued expenses and other current liabilities. On May 11, 2020, the parties reached a settlement agreement and release to resolve any and all concerns between the parties, voluntarily and without admission of copyright infringement.
(D)COVID-19
In March 2020, the World Health Organization declared the outbreak of a novel coronavirus (COVID-19) as a pandemic. As a result, public health measures have been taken by federal, state and local governments to minimize exposure to and contain the virus. Measures intended to reduce the spread of COVID-19, such as quarantines, travel restrictions and other governmental restrictions such as social distancing protocols, have has, and are likely to continue to have, an adverse impact on economic activity, including with respect to business closures, increasing unemployment levels and financial market instability. The extent or duration of the disruption on global, national, and local economies cannot be reasonably estimated at this time. However, should the pandemic and its economic impact continue for an extended period, the Company’s future business operations, including its results of operations, cash flows and financial position could be significantly affected.
15.COMMITMENTS AND CONTINGENCIES
On February 4, 2020, Indco, Inc., a majority-owned subsidiary of the Company, entered into a Purchase and Sale Agreement with 4040 Earnings Way, LLC (“Seller”) to acquire from Seller the land and building which serves as the Indco office and manufacturing facility in New Albany, Indiana, for a purchase price of $845. Indco anticipates that the purchase price will be financed with cash from operations and a loan of up to $700 from First Merchants Bank secured by the subject property. Closing is expected to occur during the third quarter of fiscal 2020, ending June 30, 20172020.
16.LEASES
The Company has operating leases for office and 2016:

For the three months ended June 30, 2017 Consolidated  Global Logistics Services  Manufacturing  Corporate 
Revenues $20,246,878  $17,963,837  $2,283,041  $- 
Forwarding expenses and cost of revenues  15,445,239   14,455,926   989,313   - 
Gross margin  4,801,639   3,507,911   1,293,728   - 
Selling, general and administrative  4,002,311   2,870,235   635,680   496,396 
Amortization of intangible assets  195,666   -   2,500   193,166 
Income (loss) from operations  603,662   637,676   655,548   (689,562)
Interest expense  184,280   116,672   67,608   - 
Identifiable assets  38,051,647   13,976,503   2,343,533   21,731,611 
Capital expenditures  5,510   -   5,510   - 

warehouse space in all districts where it conducts business. As of March 31, 2020, the remaining terms of the Company’s operating leases were between one and 58 months and certain lease agreements contain provisions for future rent increases. Payments due under the lease contracts include the minimum lease payments that the Company is obligated to make under the non-cancelable initial terms of the leases as the renewal terms are at the Company’s option and the Company is not reasonably certain to exercise those renewal options at lease commencement..
The components of lease cost for the six-month period ended March 31, 2020 are as follows:
  
Six Months Ended
March 31,
2020
 
Operating lease cost 
$
353
 
Short-term lease cost  
68
 
Total lease cost 
$
421
 

Rent expense for the six-month period March 31, 2019 was $372

Operating lease right of use asset, current portion of operating lease liabilities and long-term operating lease liabilities reported in the consolidated balance sheets for operating leases as of March 31, 2020 were $1,599, $479 and $1,142, respectively.

During the three months ended March 31, 2020, the Company entered into a new operating lease and recorded an addition $857 in operating lease right of use asset of and corresponding lease liabilities.
As of March 31, 2020, the weighted-average remaining lease term and the weighted-average discount rate related to the Company’s operating leases were 3.9 years and 6.58%, respectively. Cash paid for amounts included in the measurement of operating lease obligations were $410 for the six months ended March 31, 2020.
Future minimum lease payments under non-cancelable operating leases as of March 31, 2020 are as follows:
2020 
$
493
 
2021  
469
 
2022  
414
 
2023  
241
 
2024  221 
Total undiscounted lease payments  1,838 
Less: Imputed interest  
(217
)
Total lease obligations 
$
1,621
 

- 10 -

For the three months ended June 30, 2016 Consolidated  Global Logistics Services  Manufacturing  Corporate 
Revenues $17,505,453  $15,425,092  $2,080,361  $- 
Forwarding expenses and cost of revenues  13,118,726   12,157,139   961,587   - 
Gross margin  4,386,727   3,267,953   1,118,774   - 
Selling, general and administrative  3,460,936   2,613,697   594,186   253,053 
Amortization of intangible assets  203,237   -   2,500   200,737 
Income (loss) from operations  722,554   654,256   522,088   (453,790)
Interest expense  199,892   120,988   78,904   - 
Identifiable assets  33,761,934   12,338,707   1,744,624   19,678,603 
Capital expenditures  19,797   -   19,797   - 

For the nine months ended June 30, 2017 Consolidated  Global Logistics Services  Manufacturing  Corporate 
Revenues $55,943,398  $49,499,193  $6,444,205  $- 
Forwarding expenses and cost of revenues  42,698,641   39,810,183   2,888,458   - 
Gross margin  13,244,757   9,689,010   3,555,747   - 
Selling, general and administrative  11,206,459   8,001,437   1,911,848   1,293,174 
Amortization of intangible assets  578,997   -   7,500   571,497 
Income (loss) from operations  1,459,301   1,687,573   1,636,399   (1,864,671)
Interest expense  566,807   356,362   210,445   - 
Identifiable assets  38,051,647   13,976,503   2,343,533   21,731,611 
Capital expenditures  136,118   22,793   113,325   - 

For the nine months ended June 30, 2016 Consolidated  Global Logistics Services  Manufacturing  Corporate 
Revenues $56,728,456  $53,935,789  $2,792,667  $- 
Forwarding expense and cost of revenues  45,438,636   44,171,758   1,266,878   - 
Gross margin  11,289,820   9,764,031   1,525,789   - 
Selling, general and administrative  9,798,908   8,086,749   805,985   906,174 
Amortization of intangible assets  402,915   -   3,333   399,582 
Income (loss) from operations  1,087,997   1,677,282   716,471   (1,305,756)
Interest expense  476,665   382,804   93,861   - 
Identifiable assets  33,761,934   12,338,707   1,744,624   19,678,603 
Capital expenditures  307,550   2,905   304,645   - 

8.17.SUBSEQUENT EVENTS

CARES Act Loan

The Company has evaluated events occurring afterCoronavirus Aid, Relief and Economic Security Act, Section 7(a)(36) of the date of these financial statements throughSmall Business Act (the “CARES Act”), which was signed into law in March 2020, established the date that these financial statements were issued. There is no material subsequent events as of that date which would require disclosurePaycheck Protection Program (the “PPP”). The PPP authorizes up to $349 billion in or adjustmentsforgivable loans to small businesses. Loan amounts are forgiven to the financial statements.

- 11 -
extent proceeds are used to cover documented payroll, mortgage interest, rent and utility costs over an eight-week measurement period following loan funding. Loans have a maturity of two years and bear interest at a rate of 1.00% per annum.  Prepayments may be made at any time prior to maturity without penalty.


On April 19, 2020, the Company entered into a Loan Agreement (the “Loan Agreement”) with Santander and executed a U.S. Small Business Administration Note (the “Note”) pursuant to which the Company borrowed $2,726 (the “Loan”) from Santander pursuant to the PPP under the CARES Act.

The Loan matures on April 19, 2022 and bears interest at a rate of 1.00% per annum, payable monthly commencing on November 19, 2020. The Note may be prepaid by Janel at any time prior to maturity with no prepayment penalties. Funds from the Loan may only be used for payroll costs, costs used to continue group health care benefits, mortgage payments, rent and utilities (collectively, “Qualifying Expenses”).  Under the terms of the PPP, certain amounts of the Loan may be forgiven if they are used for Qualifying Expenses as described in the CARES Act. The Company's participation in the PPP subsequent to quarter end should allow the Company to avoid significant staff reductions in the near term.

As discussed in note 14 (C) above, the Company received a letter in December 2017 from legal counsel representing Warren in which Warren made certain allegations against the Company of copyright infringement concerning an electronic newsletter by Warren.  On May 11, 2020, the parties reached a settlement agreement and release to resolve any and all concerns between the parties, voluntarily and without admission of copyright infringement. As of March 31, 2020, the Company had a liability for settlement costs related to the Warren Matter, which is included in accrued expenses and other current liabilities.

ITEM 2.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis should be read in conjunction with our unaudited interim consolidated financial statements and related notes thereto as of and for the six months ended March 31, 2020, which have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”). Amounts presented in this section are in thousands, except share and per share data.

As used throughout this Report, “we,” “us”, “our,” “Janel,” “the Company,” “Registrant” and similar words refer to Janel Corporation and subsidiaries.

its Subsidiaries.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q (the “Report”) contains certain forward-looking statements reflecting ourthat are, or may deemed to be, “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and that reflect management’s current expectations with respect to our operations, performance, financial condition, and other developments. These forward-looking statements may generally be identified by the use of the words “may,” “will,” “intends,” “plans,” projects,” “believes,” “should,” “expects,” “predicts,” “anticipates,” “estimates,” and similar expressions.expressions or the negative of these terms or other comparable terminology. These statements are necessarily estimates reflecting management’s best judgment based upon current information and involve a number of risks, uncertainties and uncertainties.assumptions. We caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made, and readers are advised that various factors, including, but not limited to, those set forth elsewhere in this Report, could affect our financial performance and could cause our actual results for future periods to differ materially from those anticipated or projected. While it is impossible to identify all such factors, such factors include, but are not limited to, those risksthe impact of the coronavirus (“COVID-19”) pandemic and related economic effects; our strategy of expanding our business through acquisitions of other businesses; the risk that we may fail to realize the expected benefits or strategic objectives of any acquisition, or that we spend resources exploring acquisitions that are not consummated; litigation; indemnification claims and other unforeseen claims and liabilities that may arise from an acquisition; economic and other conditions in the markets in which we operate; the risk that we may not have sufficient working capital to continue operations; instability in the financial markets; the material weaknesses identified in our internal control over financial reporting; our dependence on key employees; competition from parties who sell their businesses to us and from professionals who cease working for us; terrorist attacks and other acts of violence or war; security breaches or cybersecurity attacks; competition faced by our global logistics services freight carriers with greater financial resources and from companies that operate in areas in which we plan to expand; our dependence on the availability of cargo space from third parties; recessions and other economic developments that reduce freight volumes; other events affecting the volume of international trade and international operations; risks arising from our global logistics services business’ ability to manage staffing needs; competition faced in the freight forwarding, freight brokerage, logistics and supply chain management industry; industry consolidation and our ability to gain sufficient market presence with respect to our global logistics services business; risks arising from our ability to comply with governmental permit and licensing requirements or statutory and regulatory requirements; seasonal trends; competition faced by our manufacturing (Indco) business from competitors with greater financial resources; Indco’s dependence on individual purchase orders to generate revenue; any decrease in the availability, or increase in the cost, of raw materials used by Indco; Indco’s ability to obtain and retain skilled technical personnel; risks associated with product liability claims due to alleged defects in Indco’s products; risks arising from the environmental, health and safety regulations applicable to Indco; the reliance of our Indco and life sciences businesses on a single location to manufacture their products; the ability of our life sciences business to compete effectively; the ability of our life sciences business to introduce new products in a timely manner; product or other liabilities associated with the manufacture and sale of new products and services; changes in governmental regulations applicable to our life sciences business; the ability of our life sciences business to continually produce products that meet high quality standards such as purity, reproducibility and/or absence of cross-reactivity; the controlling influence exerted by our officers and directors and one of our stockholders; our inability to issue dividends in the foreseeable future; and risks related to ownership of our common stock, including volatility and the lack of a guaranteed continued public trading market for our common stock. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those projected.  You should not place undue reliance on any of our forward-looking statements which speak only as of the date they are made.  We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. For a more detailed discussion of these factors, see our periodic reports filed with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K.

10-K for the fiscal year ended September 30, 2019.

COVID-19

The outbreak of COVID-19 has had a significant impact on global trade and our business. In late January 2020, China implemented extensive business shutdowns and work restrictions to control the outbreak, which resulted in a steep drop in exports from China. Those shutdowns and restrictions in China started to ease in March 2020, and export volumes from China increased throughout the month. The spread of COVID-19 to other parts of the world, and the strong actions taken by many countries to reduce exposure to the virus, however, have led to a sharp decrease in global economic activity during the second quarter of fiscal 2020 and a second steep drop in global import and export trade volumes, which has materially impacted our Global Logistics Services business. Specifically, in the three months ended March 31, 2020, we experienced a decrease of 9.1% in our Global Logistics Services segment revenues as a result of the global trade slowdown due to the COVID- 19 pandemic. We also experienced a significant slowdown in organic growth in both our Manufacturing and Life Sciences segments due to a slowdown in orders and in academic research due to the pandemic. Please see our results of operations discussion below for additional information. We expect demand for our products and services across all of our reporting segments, and in particular our Global Logistics Services segment to be adversely impacted for as long as global economic activity and trade volumes remain weak. A prolonged slowdown in trade volumes due to the pandemic could also significantly increase the financial challenges facing our customers. We are closely monitoring our customers’ payment performance and expect our customer credit risk will remain high as long as economic and trade disruptions persist.
In our Global Logistics Services segment, customer demand for our services in many parts of our business has been materially and negatively impacted by the mandated closure of our customers’ operations or points of sale, while customer demand for our services in other parts of our business has increased significantly as consumers stockpile goods or switch to e-commerce platforms to make purchases. We are unable to accurately predict the impact that COVID-19 will have on our operations going forward due to uncertainties regarding the severity and duration of the outbreak and additional actions that may be taken by governmental authorities. That said, we currently expect that our results of operations and financial condition will be even more significantly adversely impacted in the third quarter and fourth quarters of 2020 and subsequent periods than in the quarter ended March 31, 2020, as levels of activity in the Company’s business have historically been positively correlated to broad measures of economic activity, such as gross domestic product, and to measures of industrial economic activity, which have been negatively impacted by the pandemic.
The magnitude of the COVID-19 pandemic, including the extent of any impact on our business, financial position, results of operations or liquidity, which could be material, cannot be reasonably determined at this time due to the rapid development and fluidity of the situation. The effects of the pandemic on our business will depend on its duration and severity, whether business disruptions will continue, the pace of recovery once the pandemic subsides and the overall long-term impact on the global economy.
OVERVIEW

Janel Corporation is a holding company with subsidiaries in twothree business segments: Global Logistics Services, Manufacturing and Manufacturing.Life Sciences. The Company’s Global Logistics Services segment comprises several wholly-owned subsidiaries, collectively known as “Janel Group.” The Company’s Manufacturing segment comprisescompany strives to create shareholder value primarily through three strategic priorities: supporting its majority-owned INDCO subsidiary, which manufacturesbusinesses’ efforts to make investments and distributes industrial mixing equipment. Janel is a successor to a business originally formed in 1975. Janel is domiciled inbuild long-term profits; allocating Janel’s capital at high risk-adjusted rates of return; and attracting and retaining exceptional talent.
A management group at the state of Nevada. Its corporate headquarters is in Lynbrook, New York. Its website is located at http://www.janelcorp.com.

Janel’s managementholding company level (the “corporate group”) focuses on significant capital allocation decisions, corporate governance and support of itssupporting Janel’s subsidiaries where appropriate. The CompanyJanel expects to grow through its subsidiaries’ organic growth and by completing acquisitions. JanelWe plan to either will acquire businesses within itsour existing segments or it will expand itsour portfolio into new strategic segments. Janel’sOur acquisition strategy focuses on reasonably-priced companies with strong and capable management teams, attractive existing business economics and stable and predictable earnings power.

In September 2014,

Global Logistics Services
The Company’s Global Logistics Services segment is comprised of several wholly-owned subsidiaries (collectively “Janel Group”). Janel Group is a non-asset based, full-service provider of cargo transportation logistics management services, including freight forwarding via air-, ocean- and land-based carriers, customs brokerage services, warehousing and distribution services, and other value-added logistics services.
On November 20, 2018, we completed a business combination whereby we acquired the Company purchased the equitymembership interest of Alpha International/President Container LinesHonor Worldwide Logistics, LLC (“Alpha/PCL”Honor”), a global logistics services company. Approximatelyprovider with two U.S. locations.
On October 17, 2018, we completed a business combination whereby we acquired substantially all of the assets and certain liabilities of a global logistics services provider with one year later, it purchased the equityU.S. location.
Manufacturing
The Company’s Manufacturing segment is comprised of Liberty International,Indco, Inc. (“Liberty”Indco”). In April 2017, it purchased the equity of W.J. Byrnes & Co. (“Byrnes”). These companies, along with the legacy Janel Group, comprise Janel Corporation’s Global Logistics Services segment, which focuses on international transportation and customs clearance. In March 2016, the Company purchased INDCO, Inc. (“INDCO”) in order to diversify cash flow streams. INDCO comprises Janel Corporation’s Manufacturing segment.

The Company employs 121 full-time and five part-time people in the United States. None of these employeesIndco is covered by a collective bargaining agreement. We have experienced no work stoppages and consider relations with our employees to be good.

- 12 -

Results of Operations

Global Logistics Services – Three months ended June 30, 2017 and 2016

Revenues. Total revenues from continuing operations for the three months ended June 30, 2017 were $17,963,837, as compared to $15,425,092 for the three months ended June 30, 2016. This is an increase of $2,538,745, or 16.5%. The increase is due to revenue of $1,104,742 derived from Byrnes customers and $1,434,003 derived from new and existing non-Byrnes customers.

Forwarding Expenses. Total forwarding expenses from continuing operations for the three months ended June 30, 2017 were $14,455,926, as compared to $12,157,139 for the three months ended June 30, 2016. This is an increase of $2,298,787, or 18.9%. The increase is due to forwarding expenses of $691,411 attributable to Byrnes customers and $1,607,376 associated with new and existing non-Byrnes customers.

Certain items have been categorized as “corporate” expenses attributable to overall managementmajority-owned subsidiary of the Company that manufactures and distributes mixing equipment and apparatus for specific applications within various industries. Indco’s customer base is comprised of small- to mid-sized businesses as well as other larger customers for which Indco fulfills repetitive production orders.

Life Sciences
The Company’s Life Sciences segment is comprised of Aves Labs, Inc. (“Aves”), Antibodies Incorporated (“Antibodies”), IgG, LLC (“IgG”) and PhosphoSolutions, LLC, which are wholly-owned subsidiaries of the Company.
The Company’s Life Sciences segment manufactures and distributes high-quality monoclonal and polyclonal antibodies, diagnostic reagents and other non-segment specific activities. These expenses are discussed below under “Corporate Selling, Generalimmunoreagents for biomedical research and Administrative Expenses.” The following discussion of selling, generalprovides antibody manufacturing for academic and administrative expenses inindustry research scientists. Our Life Sciences business also produces products for other life science companies on an original equipment manufacturer (“OEM”) basis.
Through Aves, the Global Logistics Service segment excludes these “corporate” items.

Selling, General and Administrative Expenses. Total selling, general and administrative expenses from continuing operations forCompany acquired the three months ended June 30, 2017 were $2,870,235, as compared to $2,613,697 for the three months ended June 30, 2016. This is an increase of $256,538, or 9.8%. The increase primarily is due to additional selling, general and administrative costs associated with the integration of the Byrnes offices. As a percentage of revenue, selling, general and administrative expenses for the three months ended June 30, 2017 were 16.0%, as compared to 16.9% for the three months ended June 30, 2016.

Interest Expense. Total interest expense for the three months ended June 30, 2017 was $116,672, as compared to $120,988 for the three months ended June 30, 2016. This is a decrease of ($4,316), or (3.6%). The decrease was due to an improvement in working capital for the period that lowered average borrowings against the Presidential Borrowing Facility referenced below.

Income from Continuing Operations before Income Taxes. As a result of the above, income from continuing operations before income taxes for the three months ended June 30, 2017 was $521,004, as compared to $533,268 for the three months ended June 30, 2016. This is a decrease of ($12,264), or (2.3%).

Manufacturing – Three months ended June 30, 2017 and 2016

Revenues. Total revenues for the three months ended June 30, 2017 were $2,283,041, as compared to $2,080,361 for the three months ended June 30, 2016. This is an increase of $202,680, or 9.7%. The increase primarily is due to growth in demand for core INDCO manufactured mixer products.

Cost of Revenues. Total cost of revenues for the three months ended June 30, 2017 was $989,313 as compared to $961,587 for the three months ended June 30, 2016. This is an increase of $27,726, or 2.9%. The increase primarily is due to costs associated with meeting the growth in demand described above.

Gross Margin. Total gross margin for the three months ended June 30, 2017 was $1,293,728, as compared to $1,118,774 for the three months ended June 30, 2016. This is an increase of $174,954, or 15.6%. As a percentage of revenue, gross margin for the three months ended June 30, 2017 was 56.7%, as compared to 53.8% for the three months ended June 30, 2016. The increase primarily is due to growth in sales of relatively higher margin products.

Selling, General and Administrative Expenses. Total selling, general and administrative expenses for the three months ended June 30, 2017 were $635,680, as compared to $594,186 for the three months ended June 30, 2016. This is an increase of $41,494 or 7.0%. The increase primarily is due to additional sales expenses associated with the growth of the business.

Interest Expense. Total interest expense for the three months ended June 30, 2017 was $67,608 as compared to $78,904 for the three months ended June 30, 2016. This is a decrease of ($11,296), or (14.3%). The decrease is due to paydown of principal on the First Merchants Bank Borrowing Facility referenced below.

Income from Continuing Operations before Income Taxes. As a result of the above, income from continuing operations before income taxes for the three months ended June 30, 2017 was $587,940, as compared to $443,184 for the three months ended June 30, 2016. This is an increase of $144,756, or 32.7%.

- 13 -

Corporate – Three months ended June 30, 2017 and 2016

Corporate Selling, General and Administrative Expenses. Total corporate selling, general and administrative expenses from continuing operations for the three months ended June 30, 2017 were $496,396, as compared to $253,053 for the three months ended June 30, 2016. This is an increase of $243,343, or 96.2%. The increase is due to the recategorization of certain costs, previously included in the Global Logistics Services segment, as “corporate” costs. These include primarily the salaries of executives whose responsibilities have shifted from the Global Logistics Service segment to Janel Corporation corporate development.

Amortization of Intangible Assets.Total amortization of intangible assets for the three months ended June 30, 2017 was $193,166 as compared to $200,737 for the three months ended June 30, 2016. This is a decrease of ($7,571), or (3.8%). The decrease is due to an amortization adjustment related to INDCO in the first quarter following the INDCO acquisition.

Net Loss. As a result of the above, net loss for the three months ended June 30, 2017 was ($689,562), as compared to ($453,790) for the three months ended June 30, 2016. This is a decrease of ($235,772) or (52.0%).

Consolidated income taxes – Three months ended June 30, 2017 and 2016

The company recorded a net income tax provision for the three months ended June 30, 2017 of $129,419, as compared to $36,604 for the three months ended June 30, 2016.

Global Logistics Services – Nine months ended June 30, 2017 and 2016

Revenues. Total revenues from continuing operations for the nine months ended June 30, 2017 were $49,499,193, as compared to $53,935,789 for the nine months ended June 30, 2016. This is a decrease of ($4,436,596), or (8.2%). The decrease primarily is due to the lossmembership interests of a low-margin, high-revenue customer, offset by revenues from new customers, includingsmall life sciences company on July 1, 2019 and the equity interests of PhosphoSolutions, LLC. (“Phospho”) on September 6, 2019. Both acquisitions were completed primarily to expand our product offerings in Life Sciences.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES
Critical accounting estimates are those derived fromthat we believe are both significant and require us to make difficult, subjective or complex judgments, often because we need to estimate the Byrnes acquisition.

Forwarding Expenses. Total forwarding expenses from continuing operations for the nine months ended June 30, 2017 were $39,810,183 as compared to $44,171,758 for the nine months ended June 30, 2016. This is a decreaseeffect of ($4,361,575), or (9.9%). The decrease primarily is due to reduction in expenses associated with the loss of the low-margin, high-revenue customer referenced above, offset by additional expenses associated with new customer revenues, including those derived from the Byrnes acquisition.

For the current fiscal year, certain items have been categorized as “corporate” expenses attributable to overall management of Janelinherently uncertain matters. These estimates are based on historical experience and other non-segment specific activities. These expenses are discussed below under “Corporate Selling, General and Administrative Expenses.” The following discussion of selling, general and administrative expenses in the Global Logistics Service segment excludes these “corporate” items.

Selling, General and Administrative Expenses. Total selling, general and administrative expenses from continuing operations for the nine months ended June 30, 2017 were $8,001,437 as compared to $8,086,749 for the nine months ended June 30, 2016. This is a decrease of ($85,312), or (1.1%). The decrease is due to certain cost reduction initiatives enacted in prior periods. As a percentage of revenue, selling, general and administrative expenses for the nine months ended June 30, 2017 were 16.2%, as compared to 15.0% for the nine months ended June 30, 2016. This is an increase of 1.2%. The increase primarily is due to the reduction in revenues associated with the loss of the low-margin, high-revenue customer referenced above.

Interest Expense. Total interest expense for the nine months ended June 30, 2017 was $356,362, as compared to $382,804 for the nine months ended June 30, 2016. This is a decrease of ($26,442), or (6.9%). The decrease was due to an improvement in working capital for the period, which lowered average borrowings against the Presidential Borrowing Facility referenced below.

Income from Continuing Operations before Income Taxes. As a result of the above, income from continuing operations before income taxes for the nine months ended June 30, 2017 was $1,331,211, as compared to $1,294,478 for the nine months ended June 30, 2016. This is an increase of $36,733, or 2.8%.

Manufacturing – Nine months ended June 30, 2017 and 2016

INDCO, which comprises the Company’s Manufacturing segment, was purchased as of March 1, 2016. Therefore, prior period data includes only the results of the four months in that period that the Company owned INDCO.

Revenues. Total revenues for the nine months ended June 30, 2017 were $6,444,205 and $2,792,667 for the four months ended June 30, 2016.

Cost of Revenues. Total cost of revenues for the nine months ended June 30, 2017 was $2,888,458 and $1,266,878 for the four months ended June 30, 2016.

- 14 -

Gross Margin. Total gross margin for the nine months ended June 30, 2017 was $3,555,748 and $1,525,789 for the four months ended June 30, 2016.

Selling, General and Administrative Expenses. Total selling, general and administrative expenses for the nine months ended June 30, 2017 were $1,911,848 and $805,985 for the four months ended June 30, 2016.

Interest Expense. Total interest expense for the nine months ended June 30, 2017 was $210,445 and $93,861 for the four months ended June 30, 2016.

Income from Continuing Operations before Income Taxes. Income from continuing operations before income taxes for the nine months ended June 30, 2017 was $1,425,954 and $622,610 for the four months ended June 30, 2016.

Corporate – Nine months ended June 30, 2017 and 2016

Corporate Selling, General and Administrative Expenses. Total corporate selling, general and administrative expenses from continuing operations for the nine months ended June 30, 2017 were $1,293,174 as compared to $906,174 for the nine months ended June 30, 2016. This is an increase of $387,000, or 42.7%. The increase is due to the recategorization of certain costs, previously included in the Global Logistics Services segment, as “corporate” costs. These include primarily the salaries of executives whose responsibilities have shifted from the Global Logistics Service segment to Janel Corporation corporate development.

Amortization of Intangible Assets.Total amortization of intangible assets for the nine months ended June 30, 2017 was $571,497, as compared to $399,582 for the nine months ended June 30, 2016. This is an increase of $171,915, or 43.0%. The increase is due to the full-year impact of goodwill amortization associated with the March 2016 purchase of INDCO and additional goodwill amortization associated with the April 2017 purchase of Byrnes. These amounts do not include amortization associated with the INDCO term loan origination fee.

Net Loss. As a result of the above, net loss for the nine months ended June 30, 2017 was ($1,864,671) as compared to ($1,305,756) for the nine months ended June 30, 2016. This is a decrease of ($558,915) or (42.8%).

Consolidated income taxes – Nine months ended June 30, 2017 and 2016

The company recorded a net income tax provision for the nine months ended June 30, 2017 of $356,257, as compared to $75,181 for the nine months ended June 30, 2016.

Liquidity and Capital Resources

General. Our ability to satisfy our liquidity requirements, which derive from debt obligations, working capital needs, day-to-day operating expenses and capital expenditures, depends upon our future performance, which is subject to general economic conditions, competition andvarious other factors some of which are beyond our control. We depend on our commercial credit facilitiesthat we believe to fund our day-to-day operations, as there is a timing difference between our collection cycles and the timing of our payments to vendors.

Janel’s cash flow performance for the nine months ending June 30, 2017 is not necessarily indicative of future cash flow performance.

Cash Flows from Operating Activities. Net cash provided by operating activities for the nine months ended June 30, 2017 was $2,828,686, as compared to $1,039,570 for the nine months ended June 30, 2016. This is an increase of $1,789,116, or 172.1%. The increase primarily is due to changes in accounts payable and accrued liabilities, offset by changes in accounts receivable.

Cash Flows from Discontinued Operating Activities. Net cash used in discontinued operating activities for the nine months ended June 30, 2017 was $46,878, which amount was reported within continuing operations in 2017, as compared to $184,845 for the nine months ending June 30, 2016. This is a decrease of ($137,967), or (74.6%). The 2016 figure includes the settlement of a lawsuit involving the Company's discontinued food business.

Cash Flows from Investing Activities. Net cash used in investing activities for the nine months ended June 30, 2017 was $120,132, as compared to $11,042,213 for the nine months ended June 30, 2016. The decrease reflects the INDCO acquisition in the prior period.

Cash Flows from Financing Activities. Net cash (used in) provided by financing activities for the nine months ended June 30, 2017 was ($1,784,201) as compared to $9,820,642 for the nine months ended June 30, 2016. The cash used in financing activities for the nine months ending June 30, 2017 primarily went toward the second of three annual earnout payments associated with the 2014 acquisition of Alpha/PCL and toward repayment of the First Merchants Bank Borrowing Facility associated with the INDCO acquisition. The cash provided by financing activities for the nine months ended June 30, 2016 primarily came from the First Merchants Bank Borrowing Facility and the sale of additional Preferred Series C shares, both associated with the INDCO acquisition.

- 15 -

Global Logistics Services

Presidential Financial Corporation Borrowing Facility. On March 27, 2014, Janel Corporation and several of its subsidiaries within its Global Logistics Services segment (collectively, the “Janel Borrowers”), entered into a Loan and Security Agreement with Presidential Financial Corporation (“Presidential”) with respect to a revolving line of credit facility (the “Presidential Facility”). As currently amended, the Presidential Facility provides that the Janel Borrowers can borrow up to $10,000,000, limited to 85% of the Janel Borrowers’ aggregate outstanding eligible accounts receivable, subject to adjustment as set forth in the Loan and Security Agreement. Interest will accrue at an annual rate equal to five percent above the greater of (a) the prime rate of interest quoted in The Wall Street Journal from time to time, or (b) 3.25%. The Janel Borrowers’ obligationsbe appropriate under the Presidential Facility are securedcircumstance. Actual amounts and results could differ from these estimates made by the assets of the Janel Borrowers. The Loan Security Agreement requires, among other things,management. Certain accounting policies that the Company, on a monthly basis, maintain a “minimum fixed charge covenant ratio” and “tangible net worth,” both as defined. The Presidential Facility will expire on March 27, 2018, subject to earlier termination as provided in the Loan and Security Agreement, unless renewed.

Working Capital Requirements.Janel Group’s cash needs are currently met by cash flow from operations, the Presidential Facility and cash on hand. As of June 30, 2017, the Company had $662,442 available under its Presidential Facility and $1,232,102 in cash. The Company believes that current financial resources will be sufficient to finance Janel Group operations and obligations (current and long-term liabilities) for the long- and short-terms. However, Janel Group’s actual working capital needs for the long- and short-terms will depend upon numerous factors, including operating results, the cost associated with growing Janel Group either internally or through acquisition, competition, and the availability under the Presidential Facility. None of these factors can be predicted with certainty. If cash flow and available credit are not sufficient to fund working capital, Janel Group’s operations will be materially negatively impacted.

Manufacturing

First Merchants Bank Borrowing Facility.On March 21, 2016, INDCO executed a Credit Agreement with First Merchants Bank (“First Merchants”) with respect to a $6,000,000 term loan and $1,500,000 (limited to the borrowing base and reserves) revolving loan(together, the “First Merchants Facility”). Interest will accrue on the term loan at an annual rate equal to the one-month LIBOR plus either 3.75% (if INDCO’s cash flow leverage ratio is less than or equal to 2:1) or 4.75% (if INDCO’s cash flow leverage ratio is greater than 2:1). Interest accrues on the revolving loan at an annual rate equal to the one-month LIBOR plus 2.75%. INDCO’s obligations under theFirst Merchants Facilityare secured by all of INDCO’s assets,require significant management estimates and are guaranteed by the Company. The Credit Agreement requires, among other things, that INDCO, on a monthly basis, not exceed a “maximum total funded debtdeemed critical to EBITDA ratio” and maintain a “minimum fixed charge covenant ratio,” both as defined. TheFirst Merchants Facilityrequires monthly payments until the expiration date on the fifth anniversary of the loan. The loan is subject to earlier termination as provided in the Credit Agreement, unless renewed.

Working Capital Requirements.INDCO’s cash needs are currently met bycash flow from operations, the First Merchants Facility, and cash on hand. As of June 30, 2017, INDCO had $1,500,000 available under its $1,500,000 revolving facility, subject to collateral availability, and $657,366 in cash. The Company believes that the current financial resources will be sufficient to finance INDCO operations and obligations (current and long-term liabilities) for the long- and short-terms. However, actual working capital needs for the long- and short-terms will depend upon numerous factors, including operating results, the cost associated with growing INDCO either internally or through acquisition, competition, and available credit under the revolving credit facility. None of these factors can be predicted with certainty. If cash flow and available credit are not sufficient to fund working capital, INDCO’s operations will be materially negatively impacted.

Current Outlook

Theour results of operations for both Janel Group and INDCOor financial position are affected bydiscussed in the general economic cycle. Janel Group is particularly influenced by global trade levels, specifically the import and export activities of its current and prospective customers. Historically, Janel Group’s quarterly results of operations have been subject to seasonal trends which have been the result of, or influenced by, numerous factors, including climate, national holidays, consumer demand, economic conditions, the growth and diversification of Janel Group’s international network and service offerings, and other similar and subtle forces.

The Company cannot accurately forecast many of these factors, nor can it estimate accurately the relative influence of any factor and, as a result, there can be no assurance that historical patterns, if any, will continue in future periods.

Both Janel Group and INDCO are implementing business strategies to grow revenue and profitability for the current fiscal year and beyond. Janel Group’s strategy calls for additional branch offices, introduction of new revenue streams for existing locations, sales force expansion, additional acquisitions, and a continued focus on implementing lean methodologies to contain operating expenses. INDCO’s strategy calls for introductions of new product lines and wider distribution and promotion of its print- and web-based catalog.

- 16 -

In addition to supporting its subsidiaries’ growth plans, the Company may seek to grow by entering new business segments through acquisition.

Certain elements of our profitability and growth strategy, principally proposals for acquisition and accelerating our revenue growth, are contingent upon the availability of adequate financing on terms acceptable to the Company. Without adequate equity and/or debt financing, the implementation of significant aspects of the Company’s strategic growth plan may be deferred beyond the originally anticipated timing, and the Company’s operations will be materially negatively impacted.

Critical Accounting Policies and Estimates

section of Management’s Discussion and Analysis of Financial Condition and Results of Operations discussesincluded in Item 7 of our Annual Report on Form 10-K for the fiscal year ended September 30, 2019.

The Company’s consolidated financial statements which have been prepared in accordance with accounting principles generally accepted in the United States of America.U.S. GAAP. The preparation of these financial statements requires management to make estimates and assumptions about future events that affect the amounts reported in the financial statements and accompanying notes. Since future events and their effects cannot be determined with absolute certainty, the determination of estimates requires the exercise of judgment. Actual results could differ from those estimates, and such differencedifferences may be material to the financial statements. The most significant accounting estimates inherent in the preparation of our financial statements include estimates as to revenue recognition, the appropriate carrying value of certain assets and liabilities which are not readily apparent from other sources, primarily allowance for doubtful accounts, accruals for transportation and other direct costs, accruals for cargo insurance, and deferred income taxes. Management bases its estimates on historical experience and on various assumptions which are believed to be reasonable under the circumstances. We reevaluate these significant factors as facts and circumstances change. Historically, actual results have not differed significantly from management’sNote 1 of the notes to consolidated financial statements included herein includes a summary of the significant accounting policies and methods used in the preparation of our consolidated financial statements. The following is a brief discussion of certain accounting policies and estimates.

Management believes that the nature of the Company’s business is such that there are a few if any, complex challenges in accounting for operations. Revenue recognition is considered the critical accounting policy.

Revenue Recognition

Global Logistics Services

The Company’s Global Logistics Services segment comprises several wholly-owned subsidiaries, collectively known as “Janel Group.” Janel Group derives its revenues from air freight, ocean freight and customs brokerage services.

In its capacity as an air freight and ocean freight service provider, Janel Group acts as an indirect carrier: it does not own any transportation assets. Rather, it purchases transportation services from direct carriers (airlines, steam ship lines, etc.) and resells them to its customers. By consolidating shipments from multiple customers and availing itself of its buying power, Janel Group is able to negotiate favorable rates from direct carriers and offer to its customers better rates than the customers could obtain themselves.

Air freight revenues include charges for carrying shipments when Janel Group acts as an air freight consolidator. Ocean freight revenues include charges for carrying shipments when Janel Group acts as a Non-Vessel Operating Common Carrier (“NVOCC”). Janel Group issues a House Airway Bill (“HAWB”) or a House Ocean Bill of Lading (“HOBL”) to customers as the contract of carriage. In turn, when the freight is physically tendered to a direct carrier, Janel Group receives a contract of carriage known as a Master Airway Bill for air freight shipments and a Master Ocean Bill of Lading for ocean freight shipments. At this point, the risk of loss passespolicy due to the carrier; however, in order to claimcomplexity of arranging and managing global logistics and supply-chain management transactions.

Income taxes
The Company uses the asset and liability method of accounting for any such loss, the customer is obligated to pay the freight charges.

Based upon the terms of the contract of carriage, Janel Group recognizes air freight and ocean freight revenues when the freight is tendered to the direct carrier. Costs related to the shipments are recognized at the same time.

In some cases, Janel Group acts as an agent for the shipper, in which case it does not issue a HAWB or a HOBL. Revenues from these activities include only commission and fees earned for services performed. They are recognized upon completion of services.

In its capacity as a customs broker, Janel Group provides multiple services, including preparing documentation necessary for clearing shipments through U.S. customs, calculating and providing for payment of duties and other charges on its customers’ behalves and arranging for required inspections. Revenues derived from these activities are recognized upon completion of the services.

- 17 -

The movement of freight may require multiple services. In most instances, Janel Group may perform multiple services including destination break bulk and value-added services such as local transportation, distribution services and logistics management. Each of these services has separate fee that is recognized as revenue upon completion of the service.

Customers frequently request an all-inclusive rate for a set of services known as “door-to-door services.” In these cases, the customer is billed a single rate for all services from pickup at origin to delivery. The allocation of revenue and expense among the components of services when provided under an all-inclusive rate are done in an objective manner on a fair value basisincome taxes in accordance with Emerging Issues Task Force (EITF) 00-21, “Revenue Arrangements with Multiple Deliverables.Accounting Standards Codification Topic 740, “Income Taxes.

Manufacturing

The Company’s Manufacturing segment comprises its majority-owned INDCO subsidiary, which manufactures and distributes industrial mixing equipment. INDCO derives its revenues from product sales and shipping and handling charges, net of actual product returns and discounts. Since INDCO’s standard shipping terms are FOB shipping point, revenue primarily Under this method, income tax expense is recognized onfor the date productsamount of: (i) taxes payable or refundable for the current year and (ii) deferred tax consequences of temporary differences resulting from matters that have been recognized in an entity’s financial statements or tax returns. Deferred tax assets and liabilities are shippedmeasured using enacted tax rates expected to the customer. INDCO recognizes revenues from both e-commerce and traditional channelsapply to taxable income in the same manner. Accounts receivableyears in which those temporary differences are stated at their estimated net realizable value. INDCO makes an allowance for doubtful accounts basedexpected to be recovered or settled. The effect on its analysisdeferred tax assets and liabilities of customer accounts and its historical experience with accounts receivable write-offs.

a change in tax rates is recognized in the results of operations in the period that includes the enactment date.

Estimates

While judgments and estimates are a necessary component of any system of accounting, the Company’s use of estimates primarily is limited primarily to the following areas that in the aggregate are not a major component of the Company’s consolidated statements of operations:

a.accounts receivable valuation;

b.the useful lives of long-term assets;

c.the accrual of costs related to ancillary services the Company provides;

d.accrual of tax expense on an interim basis;

e.deferred tax valuation allowance; and

f.impairment of intangible assets.

accounts receivable valuation;
the useful lives of long-term assets;
the accrual of costs related to ancillary services the Company provides;
accrual of tax expense on an interim basis; and
inventory valuation.
Management believes that the methods utilized in these areas are non-aggressive in approach and consistent in application. Management further believes that there are limited, if any, alternative accounting principles or methods which could be applied to the Company’s transactions. While the use of estimates means that actual future results may be different from those contemplated by the estimates, the Company believes that alternative principles and methods used for making such estimates would not produce materially different results than those reported.

Recent

Critical Accounting PronouncementsPolicies and Estimates Applicable to the Global Logistics Services Segment
Revenue Recognition
Revenues are derived from customs brokerage services and from freight forwarding services.
Customs brokerage services include activities required for the clearance of shipments through government customs regimes, such as preparing required documentation, calculating and providing for payment of duties and other charges on behalf of customers, arranging required inspections and arranging final delivery.
Freight forwarding may require multiple services, including long-distance shipment via air, ocean or ground assets, destination handling (“break bulk”), warehousing, distribution and other logistics management activities. As an asset-light business, Janel Group owns none of the assets by which it fulfills its customers’ logistics needs. Rather, it purchases the services its customers need from asset owners, such as airlines and steamship lines, and resells them. By consolidating shipments from multiple customers, Janel Group can negotiate terms of service with asset owners that are more favorable than those the customers could negotiate themselves.
Revenue is recognized upon transfer of control of promised services to customers. With respect to its Global Logistics Services segment, t

Fromhe Company has determined that in general each shipment transaction or service order constitutes a separate contract with the customer. When the Company provides multiple services to a customer, different contracts may be present for different services.

The Company typically satisfies its performance obligations as services are rendered at a point in time. A typical shipment would include services rendered at origin, such as pick-up and delivery to port, freight services from origin to destination port and destination services, such as customs clearance and final delivery. The Company measures the performance of its obligations as services are completed at a point in time during the life of a shipment, including services at origin, freight and destination. The Company fulfills nearly all of its performance obligations within a one-to two-month period.
The Company evaluates whether amounts billed to time, new accounting pronouncements are issuedcustomers should be reported as gross or net revenue. Generally, revenue is recorded on a gross basis when the Company is primarily responsible for fulfilling the promise to provide the services, when it has discretion in setting the prices for the services to the customers, and the Company has the ability to direct the use of the services provided by the third party. Revenue is recognized on a net basis when we do not have latitude in carrier selection or establish rates with the carrier.
In the Global Logistics Services segment, the Company disaggregates its revenues by its four primary service categories: ocean import and export, freight forwarding, customs brokerage and air import and export.

Critical Accounting Policies and Estimates Applicable to the Manufacturing and Life Sciences Segments
Revenue Recognition-Manufacturing

Revenues from Indco are derived from the engineering, manufacture and delivery of specialty mixing equipment and accessories. Indco receives customer product orders via telephone, email, internet or fax. The pricing of each standard product sold is listed in Indco’s print and web-based catalog. Customer specific products are priced by quote. A sales order acknowledgement is sent to every customer for every order to confirm pricing and the specifications of the products ordered. The revenue is recognized at a point in time when the product is shipped to the customer.

Revenue Recognition-Life Sciences

Revenues from the Life Sciences segment are derived from the sale of high-quality monoclonal and polyclonal antibodies, diagnostic reagents and diagnostic kits and other immunoreagents for biomedical research and antibody manufacturing. Revenues are recognized when products are shipped and risk of loss is transferred to the carrier(s) used.
NON-GAAP FINANCIAL MEASURES
While we prepare our financial statements in accordance with U.S. GAAP, we also utilize and present certain financial measures, in particular adjusted operating income, which is not based on or included in U.S. GAAP (we refer to these as “non-GAAP financial measures”).
Net Revenue
Net revenue is a non-GAAP measure calculated as total revenue less forwarding expenses attributable to the Company’s Global Logistics Services segment. Our total revenue represents the total dollar value of services and goods we sell to our customers. Forwarding expenses attributable to the Company’s Global Logistics Services segment refer to purchased transportation and related services including contracted air, ocean, rail, motor carrier and other costs. Total revenue can be influenced greatly by changes in transportation rates or other items, such as fuel prices, which we do not control. Management believes that providing net revenue is useful to investors as net revenue is the primary indicator of our ability to source, add value and sell services and products that are provided by third parties, and we consider net revenue to be our primary performance measurement. The difference between the rate billed to our customers (the sell rate) and the rate we pay to the carrier (the buy rate) is termed “net revenue”, “yield” or “margin.” As presented, net revenue matches gross margin.
Adjusted Operating Income
As a result of our acquisition strategy, our net income includes material non-cash charges relating to the amortization of customer-related intangible assets in the ordinary course of business as well as other intangible assets acquired in our acquisitions. Although these charges may increase as we complete more acquisitions, we believe we will be growing the value of our intangible assets such as customer relationships. Because these charges are not indicative of our operations, we believe that adjusted operating income is a useful financial measure for investors because it eliminates the effect of these non-cash costs and provides an important metric for our business that is more representative of the actual results of our operations.
Adjusted operating income (which excludes the non-cash impact of amortization of intangible assets, stock-based compensation and amortization of acquired inventory valuation) is used by management as a supplemental performance measure to assess our business’s ability to generate cash and economic returns.
Adjusted operating income is a non-GAAP measure of income and does not include the effects of preferred stock dividends, interest and taxes.
We believe that net revenue and adjusted operating income provide useful information in understanding and evaluating our operating results in the same manner as management. However, net revenue and adjusted operating income are not financial measures calculated in accordance with U.S. GAAP and should not be considered as a substitute for total revenue, operating income or any other operating performance measures calculated in accordance with U.S. GAAP. Using these non-GAAP financial measures to analyze our business has material limitations because the calculations are based on the subjective determination of management regarding the nature and classification of events and circumstances that users of the financial statements may find significant.
In addition, although other companies in our industry may report measures titled net revenue, adjusted operating income or similar measures, such non-GAAP financial measures may be calculated differently from how we calculate our non-GAAP financial measures, which reduces their overall usefulness as comparative measures. Because of these limitations, you should consider net revenue and adjusted operating income alongside other financial performance measures, including total revenue, operating income and our other financial results presented in accordance with U.S. GAAP.
The following table sets forth a reconciliation of operating income to adjusted operating income:
  
Three Months Ended
March 31,
  
Six Months Ended
March 31,
 
  
2020
  
2019
  
2020
  
2019
 
  (in thousands)  (in thousands) 
Operating (loss) income 
$
(831
)
 
$
442
  
$
(872
)
 
$
1,332
 
Amortization of intangible assets(1)
  
243
   
236
   
486
   
444
 
Stock-based compensation(2)
  
75
   
107
   
149
   
236
 
Amortization of acquired inventory valuation(3)
  
227
   
67
   
447
   
129
 
Adjusted operating income 
$
(286
)
 
$
852
  
$
210
  
$
2,141
 


(1)
Amortization of intangible assets represents non-cash amortization expense or impairment expense, if any, attributable to acquisition-related intangible assets, including any portion that is allocated to noncontrolling interests. Management believes that making this adjustment aids in comparing the Company’s operating results with other companies in our industry that have not engaged in acquisitions.
(2)
The Company eliminates the impact of stock-based compensation because it does not consider such non-cash expenses to be indicative of the Company’s core operating performance. The exclusion of stock-based compensation expenses also facilitates comparisons of the Company’s underlying operating performance on a period-to-period basis.
(3)
The Company has excluded the impact of amortization of acquired inventory valuation in connection with acquisitions as such adjustments represent non-cash items, are not consistent in amount and frequency and are significantly impacted by the timing and size of the Company’s acquisitions.
Results of Operations – Segment Financial Accounting Standards BoardResults – Three and Six Months Ended March 31, 2020 and 2019
The following table sets forth our segment financial results:
  
Three Months Ended
March 31,
  
Six Months Ended
March 31,
 
  
2020
  
2019
  
2020
  
2019
 
  (in thousands)       
Revenue:            
Global Logistics Services 
$
15,328
  
$
16,865
  
$
31,407
  
$
35,670
 
Manufacturing  
2,056
   
2,452
   
3,926
   
4,533
 
Life Sciences  
1,737
   
1,652
   
3,609
   
3,093
 
Total Revenues  
19,121
   
20,969
   
38,942
   
43,296
 
                 
Gross Profit:                
Global Logistics Services  
3,713
   
3,908
   
7,705
   
8,295
 
Manufacturing  
1,148
   
1,375
   
2,173
   
2,523
 
Life Sciences  
1,135
   
1,087
   
2,405
   
2,039
 
Total Gross Profit  
5,996
   
6,370
   
12,283
   
12,857
 
                 
Income (loss) from Operations:                
Global Logistics Services  
(239
)
  
440
   
115
   
1,467
 
Manufacturing  
447
   
616
   
790
   
1,056
 
Life Sciences  
64
   
363
   
354
   
608
 
Total Income from Operations by Segment  
272
   
1,419
   
1,259
   
3,131
 
                 
Corporate administrative expense  
(860
)
  
(741
)
  
(1,645
)
  
(1,355
)
Amortization expense  
(243
)
  
(236
)
  
(486
)
  
(444
)
Interest expense, net  
(141
)
  
(198
)
  
(304
)
  
(360
)
Net (loss) income before taxes  
(972
)
  
244
   
(1,176
)
  
972
 
Income tax benefit (expense)  
35
   
(69
)
  
119
   
(253
)
Net (loss) income 
$
(937
)
 
$
175  
$
(1,057
)
 
$
719 
Preferred stock dividends  (175
)
  (148
)
  (326
)
  (270
)
Net (Loss) Income available to Common Stockholders 
$
(1,112
)
 
$
27
  
$
(1,383
)
 
$
449
 

Results of Operations – Janel Corporation
The following table sets forth our corporate group expenses:
  
Three Months Ended
March 31,
  
Six Months Ended
March 31,
 
  
2020
  
2019
  
2020
  
2019
 
  (in thousands) 
Corporate expenses 
$
785
  
$
582
  
$
1,470
  
$
1,045
 
Amortization of intangible assets  
243
   
236
   
486
   
444
 
Stock-based compensation  
37
   
142
   
111
   
236
 
Merger and acquisition expenses  
38
   
17
   
64
   
74
 
Total corporate expenses 
$
1,103
  
$
977
  
$
2,131
  
$
1,799
 

Expenses
Corporate expenses, which include amortization of intangible assets, stock-based compensation and merger and acquisition expenses, increased by $126 to $1,103, or other standard setting bodies that may have12.9% in the three months ended March 31, 2020 as compared to $977 for the three months ended March 31, 2019. Expenses increased to $2,131 in the six months ended March 31, 2020 as compared to $1,799 in the six months ended March 31, 2019, a $332 or 18.5% increase. The increases in both periods were due primarily to higher accounting-related professional expenses and higher merger and acquisition related expenses partially offset by lower stock-based compensation expense for the quarter.
Amortization of Intangible Assets
For the three months ended March 31, 2020 and 2019, corporate amortization expenses were $243 and $236, respectively, an impactincrease of $7, or 3.0%. For the six months ended March 31, 2020 and 2019, corporate amortization expenses were $486 and $444, respectively, an increase of $42, or 9.5%. The increases in both periods were primarily related to acquisitions.
Interest Expense
For the three months ended March 31, 2020, interest expense for the consolidated company decreased $57, or 28.9%, to $141 from $198 for the three months ended March 31, 2019. For the six months ended March 31, 2020 and 2019, interest expense was $304 and $360, respectively, a decrease of $56, or 15.5%. The decrease in both periods was primarily due to lower prevailing interest rates and lower rates on the amended revolving line of credit facility, partially offset by average higher debt levels on the senior secured term loan facility.
Income Taxes
On a consolidated basis, the Company recorded an income tax benefit of $35 for the three months ended March 31, 2020, as compared to an income tax expense of $69 for the three months ended March 31, 2019. For the six months ended March 31, 2020, the Company recorded an income tax benefit of $119 versus an expense of $253 in the prior year period. The income tax benefit in both periods was primarily due to the increase in pretax loss. In 2016, a deferred tax asset was established to reflect a net operating loss carryforward, which the Company has begun using, and is expected to continue to use, through ongoing profitability.
Preferred Stock Dividends
Preferred stock dividends include any dividends accrued but not paid on the Company’s accountingSeries C Cumulative Preferred Stock (the “Series C Stock”). For the three months ended March 31, 2020 and reporting.2019, preferred stock dividends were $175 and $148, respectively. For the six months ended March 31, 2020 and 2019, the preferred stock dividends we $326 versus $270, respectively. The increase of $27 for the three-month period and $56 for the six-month period were the result of an increase in the dividend rate as of January 1, 2020 to 7% and a higher outstanding amount of accrued and unpaid dividends. See note 9 to the consolidated financial statements for additional information.
Net (Loss) Income
Net loss was ($937) or ($1.08) per diluted share, for the three months ended March 31, 2020 compared to net income of $175, or $0.18 per diluted share, for the three months ended March 31, 2019. For the six months ended March 31, 2020, net (loss) income totaled ($1,057) or ($1.22) per share compared to $719 or $0.77 per share for the six months ended March 31, 2019. The loss was primarily due to lower revenues and gross profit and higher selling, general and administrative expenses across our businesses in both periods.
(Loss) Income Available to Common Stockholders
Loss available to holders of common shares was ($1,112), or ($1.29) per diluted share, for the three months ended March 31, 2020 compared to income of $27, or $0.03 per diluted share, for the three months ended March 31, 2019. In the six months ended March 31, 2020 loss available to holders of common shares totaled ($1,383) or ($1.60) per share compared to $449 or $0.48 per share for the six months ended March 31, 2019. The decrease primarily was due to lower revenues and gross profit and higher selling, general and administrative expenses across our businesses in both periods and an increase in the dividend rate with respect to the Series C Stock as of January 1, 2020 to 7%.
Results of Operations - Global Logistics Services
Our Global Logistics Services business helps its clients move and manage freight efficiently to reduce inventories and to increase supply chain speed and reliability. Key services include customs entry filing, arrangement of freight forwarding by air, ocean and ground, warehousing, cargo insurance procurement, logistics planning, product repackaging and online shipment tracking.
Global Logistics Services – Selected Financial Information:
  
Three Months Ended
March 31,
  
Six Months Ended
March 31,
 
  
2020
  
2019
  
2020
  
2019
 
  (in thousands) 
Revenue 
$
15,328
  
$
16,865
  
$
31,407
  
$
35,670
 
Forwarding expenses  
11,615
   
12,957
   
23,702
   
27,375
 
Net revenue  
3,713
   
3,908
   
7,705
   
8,295
 
Gross profit margin  
24.2
%
  
23.2
%
  
24.5
%
  
23.3
%
Selling, general & administrative  
3,952
   
3,468
   
7,590
   
6,828
 
(Loss) income from operations 
$
(239
)
 
$
440
  
$
115
  
$
1,467
 

Revenue
Total revenue decreased 9.1% to $15,328 for the three months ended March 31, 2020, compared to $16,865 in the three months ended March 31, 2019. The decrease in revenue was driven by the global trade slowdown, in particular the steep reductions in global import and export trade volumes, due to the COVID-19 pandemic.
Total revenue for the six months ended March 31, 2020 and 2019 was $31,407 and $35,670 respectively, a decrease of $4,263 or 11.9%. The decrease in revenue was largely due to the impact of the global trade slowdown due to the COVID-19 pandemic and customers in the prior year period moving freight ahead of certain governmental trade policies. Acquired revenue from two acquisitions completed during fiscal 2019 slightly offset some of the revenue decline in the six-month period.
Net Revenue
Net revenue for the three months ended March 31, 2020 and 2019 was $3,713 and $3,908 respectively, a decrease of $195, or 5.0%. The decrease reflected an organic decline for the quarter in our base business due to volume pressures from the COVID-19 pandemic partially offset by improved freight purchase rates. Net revenue as a percentage of gross revenue increased to 24.2% versus 23.2% for the prior year period due to lower freight rates.
Net revenue for the six months ended March 31, 2020 and 2019 was $7,705 and $8,295 respectively, a decrease of $590, or 7.1%, as a result of organic declines due to the COVID-19 pandemic partially offset by contributions from two acquisitions and improved freight purchase rates in the current year period, whereas we benefited in the prior year period from customers moving freight in advance of certain governmental trade policies. Net revenue as a percentage of gross revenue increased in the six-month period to 24.5% versus 23.3% in the prior year period due to lower freight rates.
Selling, General and Administrative Expenses
Selling, general and administrative expenses for the three months ended March 31, 2020 were $3,952, as compared to $3,468 for the three months ended March 31, 2019. This increase of $484, or 14.0%, was largely attributable to the reserve for the settlement of threatened litigation and additional expenses from maintaining current staff levels. As a percentage of revenue, selling, general and administrative expenses were 25.8% and 20.6% of revenue for the three months ended March 31, 2020 and 2019, respectively.
Selling, general and administrative expenses for the six months ended March 31, 2020 and 2019 were $7,590 and $6,828 respectively. The increase of $762, or 11.16% reflected the reserve for the settlement of threatened litigation and higher expenses from prior year acquisitions. As a percentage of revenue, selling, general and administrative expenses were 24.2% and 19.1% of revenue for the six months ended March 31, 2019 and 2018, respectively.
(Loss) Income from Operations
For the three months ended March 31, 2020, loss from operations before income taxes was $(239) as compared to income from operations of $440 for the three months ended March 31, 2019, a decrease of $679 or 154.3%. Operating income in the three-month period declined due to the impact of the global trade slowdown associated with the COVID-19 pandemic and the reserve for the settlement of threatened litigation.
For the six months ended March 31, 2020 and 2019, income from operations before income taxes was $115 and $1,467 respectively, a decrease of $1,352 or 92.2%. Income from operations declined as a result of the impact of the COVID-19 pandemic, a shift in volume experienced during the first quarter of fiscal 2019 that did not recur and the reserve for the settlement of threatened litigation, partially offset by contributions from acquisitions experienced during the first quarter. Our operating margin as a percentage of net revenue for the three months ended March 31, 2020 was 6.4%, versus 11.3% in the prior year period.
Results of Operations - Manufacturing
The Company’s Manufacturing segment includes its majority-owned Indco subsidiary, which manufactures and distributes industrial mixing equipment.
Manufacturing – Selected Financial Information:
  
Three Months Ended
March 31,
  
Six Months Ended
March 31,
 
  
2020
  
2019
  
2020
  
2019
 
  (in thousands)       
Revenue 
$
2,056
  
$
2,452
  
$
3,926
  
$
4,533
 
Cost of sales  
908
   
1,077
   
1,753
   
2,010
 
Gross profit  
1,148
   
1,375
   
2,173
   
2,523
 
Gross profit margin 
$
55.8
%
 
$
56.1
%
  
55.3
%
  
55.7
%
Selling, general & administrative  701   759   1,383   1,467 
Income from Operations 
$
447
  
$
616
  
$
790
  
$
1,056
 

Revenue
Total revenue decreased 16.1% to $2,056 in the three months ended March 31, 2020, compared to $2,452 for the three months ended March 31, 2019. Total revenue decreased 13.4% to $3,926 in the six months ended March 31, 2019, compared to $4,533 in the six months ended March 31, 2018. The revenue decline in both periods reflected a decline in volume across the business relative to the prior year periods, due to the slowdown late in the quarter related to the COVID-19 pandemic.
Gross Profit
Gross profit decreased 16.5% to $1,148 in the three months ended March 31, 2020, compared to $1,375 for the three months ended March 31, 2019. Gross profit margin for the three-month periods ended March 31, 2020 and 2019 was 55.8% and 56.1%, respectively. Gross profit margin for the six months ended March 31, 2020 decreased to 55.3%, compared to 55.7% for the six months ended March 31, 2019. In both the three- and six-month periods, gross profit margin was relatively flat as the mix of business remained consistent.
Selling, General and Administrative Expenses
Selling, general and administrative expenses decreased 7.6% to $701 in the three months ended March 31, 2020, compared to $759 in the three months ended March 31, 2019. Selling, general and administrative expenses decreased 5.7% to $1,383 in the six months ended March 31, 2020, compared to $1,467 in the six months ended March 31, 2020. The decrease in both periods was related to the decline in revenue, partially offset by management’s decision to maintain operational capabilities.
Income from Operations
Income from operations was $447 for the three months ended March 31, 2020 compared to $616 for the three months ended March 31, 2019, representing a 27.4% decrease from the prior year period. Income from operations of $790 for the six months ended March 31, 2020 decreased 25.2% compared to $1,056 for the six months ended March 31, 2019. Operating profit decreased in both periods due to lower revenue growth without corresponding expense reductions.
Results of Operations – Life Sciences
The Company’s Life Sciences segment manufactures and distributes high-quality monoclonal and polyclonal antibodies, diagnostic reagents and other immunoreagents for biomedical research and provides antibody manufacturing for academic and industry research scientists. Our Life Sciences business also produces products for other life science companies on an OEM basis.
Life Sciences – Selected Financial Information:
  
Three Months Ended
March 31,
  
Six Months Ended
March 31,
 
  
2020
  
2019
  
2020
  
2019
 
  (in thousands)       
Revenue 
$
1,737
  
$
1,652
  
$
3,609
  
$
3,093
 
Cost of sales  
602
   
565
   
1,204
   
1,054
 
Gross profit  
1,135
   
1,087
   
2,405
   
2,039
 
Gross profit margin  
65.3
%
  
65.8
%
  
66.6
%
  
65.9
%
Selling, general & administrative  1,071   724   2,051   1,431 
Income from Operations 
$
64
  
$
363
  
$
354
  
$
608
 

Revenue
Total revenue was $1,737 and $1,652 for the three months ended March 31, 2020 and 2019, respectively, an increase of $85 or 5.1%. Total revenue was $3,609 and $3,093 for the six months ended March 31, 2020 and 2019, respectively. Acquisitions accounted all of the increase in both periods, as organic growth declined at a double-digit rate for the quarter and at a mid-single digit rate in the six-month period, each as compared to the prior year period, due to the slowdown in academic research late in the quarter related to the COVID-19 pandemic.
Gross Profit and Gross Profit Margin
Gross profit was $1,135 and $1,087 for the three months ended March 31, 2020 and 2019, respectively, an increase of $48 or 4.4%. Amortization of acquired inventory in the quarter totaled $227 versus $67 in the prior year period due to our two prior year acquisitions. In the three months ended March 31, 2020 and 2019, the Life Sciences segment had gross profit margins of 65.3% and 65.8%, respectively. Gross profit margin decreased in the quarter compared to prior year period due to acquisitions and favorable product mix.
Gross profit was $2,405 and $2,039 for the six months ended March 31, 2020 and 2019, respectively. In the six months ended March 31, 2020 the amortization of acquired inventory totaled $447 versus $129 in the prior year. In the six months ended March 31, 2020, the Life Sciences segment had a gross profit margin of 66.6% compared to 65.9% for the prior year period.

Selling, General and Administrative Expenses
Selling, general and administrative expenses were $1,071 and $724 for the three months ended March 31, 2020 and 2019, respectively, an increase of $347 or 47.9%, largely due to acquired businesses. Selling, general and administrative expenses were $2,051 and $1,431 for the six months ended March 31, 2020 and 2019, respectively. The increase was largely due to acquired businesses.
Income from Operations
Income from operations for the three months ended March 31, 2020 and 2019 was $64 compared to $363, in the prior year. The decline in operating income reflected higher amortization of acquired inventory due to acquisitions and a slowdown in academic research late in the quarter related to the COVID-19 pandemic. Income from operations for the six months ended March 31, 2020 and 2019 was $354 and $608, respectively. The decline reflected higher amortization of acquired inventory due to acquisitions. As a percentage of revenue income from operations in the six months ended March 31, 2020 declined to 9.8% versus 19.7% due to higher amortization of acquired inventory. Absent these non-cash expenses, adjusted operating income increased to $801 versus $736 in the prior year period due to acquisitions, offset by lower organic revenue.
LIQUIDITY AND CAPITAL RESOURCES
General
Our ability to satisfy liquidity requirements, including satisfying debt obligations and fund working capital, day-to-day operating expenses and capital expenditures, depends upon future performance, which is subject to general economic conditions, competition and other factors, some of which are beyond Janel’s control. Our Global Logistics Services segment depends on commercial credit facilities to fund day-to-day operations as there is a difference between the timing of collection cycles and the timing of payments to vendors. Generally, Janel does not make significant capital expenditures.
As a customs broker, our Global Logistics Services segment makes significant cash advances for a select group of our credit-worthy customers. These cash advances are for customer obligations such as the payment of duties and taxes to customs authorities primarily in the U.S. Increases in duty rates could result in increases in the amounts we advance on behalf of our customers. Cash advances are a “pass through” and are not recorded as a component of revenue and expense. The billings of such advances to customers are accounted for as a direct increase in accounts receivable from the customer and a corresponding increase in accounts payable to governmental customs authorities. These “pass through” billings can influence our traditional credit collection metrics. For customers that meet certain criteria, we have agreed to extend payment terms beyond our customary terms. Management believes that it has established effective credit control procedures and has historically experienced relatively insignificant collection problems.
The COVID-19 pandemic has negatively impacted our liquidity and cash flows. As discussed in greater detail in note 17 to the consolidated financial statements, on April 19, 2020, we entered into a loan agreement with Santander and executed a U.S. Small Business Administration Note pursuant to which we borrowed $2,726 from Santander pursuant to the Paycheck Protection Program under The Coronavirus Aid, Relief and Economic Security Act, Section 7(a)(36) of the Small Business Act in order to be able to continue to cover our payroll costs, group health care benefits, mortgage payments, rent and utilities. The duration and magnitude of the pandemic is not reasonably estimable at this point, and if the pandemic persists, our liquidity and capital resources could be further negatively impacted.
As of March 31, 2020, the Company’s cash and working capital deficiency (current assets minus current liabilities) were $1,928 and $8,302, respectively, as compared to $2,163 and $6,190 as of September 30, 2019. The increase in working capital deficiency is considered nominal, representing relatively stable collections from customers and payments of vendors.
Janel’s cash flow performance for the three and six-months ended March 31, 2020 is not necessarily indicative of future cash flow performance.
Cash flows from operating activities
Net cash provided by operating activities for the six months ended March 31, 2020 and 2019 was $1,209 and $1,272, respectively. The decrease in cash provided by operations for the six months ended March 31, 2020 was driven principally by the higher net loss, partially offset by timing of cash collections for accounts receivables and cash payments on accounts payables for the six-month period ended March 31, 2020.
Cash flows from investing activities
Net cash used in investing activities totaled $247 for the six months ended March 31, 2020, versus $2,188 for the prior year period. During the six months ended March 31, 2020, the Company used $116 for final purchase price adjustments related to an acquisition in the prior year compared to $1,935 for the six months ended March 31, 2019. The Company belis that such recently issued accounting pronouncementsalso used $131 for the acquisition of property and other authoritative guidanceequipment for which the effective date issix months ended March 31, 2020 compared to $253 for the six months ended March 31, 2019.
Cash flows from financing activities
Net cash used in financing activities was ($1,197) for the future either will not have an impactsix months ended March 31, 2020, versus $1,712 provided by financing activities for the six months ended March 31, 2019. Net cash used in financing activities for the six months ended March 31, 2020 was primarily a result of reduced outstanding balances on its accountingour line of credit. Net cash provided by financing activities for the six months ended March 31, 2019 primarily funded our acquisition efforts.
Off-Balance Sheet Arrangements
As of March 31, 2020, we had no off-balance sheet arrangements or reporting or that such impact will not be material to its financial position, results of operations, and cash flows when implemented.

obligations.
ITEM 4.CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures
The Company maintains disclosure controls and procedures (asdesigned to ensure that term is definedinformation required to be disclosed in Rules 13a-15(e) and 15d-15(e)reports filed under the Securities Exchange Act of 1934, as amended (“Exchange(the “Exchange Act”)) that are designed to provide reasonable assurance that information, which is required to be disclosed in the reports that it files or submits under the Exchange Act,, is recorded, processed, summarized and reported within the specified time periods, specified in the rules and forms of the Securities and Exchange Commission, andthat such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.
Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in a timely manner. TheRules 13a-15(e) and 15d-15(e) of the Exchange Act) as of March 31, 2020, the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have evaluatedconcluded that, because material weaknesses in the Company’s internal control over financial reporting existed at September 30, 2018 and had not been remediated by the end of the period covered by this system ofQuarterly Report on Form 10-Q, the Company’s disclosure controls and procedures were not effective as of the end of the period covered by this quarterly report,Quarterly Report on Form 10-Q.  These material weaknesses in the Company’s internal control over financial reporting and the Company’s remediation efforts are described below.
Material Weaknesses in Internal Control Over Financial Reporting
The Company’s management, including our Chief Executive Officer and Chief Financial Officer, have identified material weaknesses in the Company’s internal control over financial reporting. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis.
In connection with the preparation of the Company’s Annual Report on Form 10-K, management identified the following material weaknesses as of September 30, 2019 related to our Life Sciences segment:
The Company had inadequate controls over the following:
(1) recording of sales orders and timeliness of revenue recognition in accordance with ASC Topic 606, Revenue from Contracts with Customers – Principal Agent Consideration (“ASC Topic 606”),
(2) recording of journal entries and approvals,
(3) payroll recording and processing of payroll changes,
(4) vendor setup and creation,
(5) documentation of inventory cycle count results, and
(6) recording of inventory and updating of standard costing worksheets used in the valuation of inventory.
A number of deficiencies were identified related to the design, implementation and effectiveness of certain information technology general controls, including segregation of duties, user access, change management, data back-ups and review of SOC 1 and 2 reports from critical vendors, some of which could have a direct impact on the Company’s financial reporting.
In addition, as of September 30, 2019, management identified the following additional deficiency related to the Company’s Global Logistics Services segment:
Management did not have an effective process or control in place to perform an assessment of gross versus net revenue recognition criteria in accordance with ASC Topic 606.
Based on this assessment and the material weaknesses described above, management concluded that the Company’s internal control over financial reporting was not effective as of September 30, 2019 and had not been remediated by the end of the period covered by this Quarterly Report on Form 10-Q.
Our management performed analyses, substantive procedures and other post-closing activities with the assistance of consultants and other professional advisors in order to ensure the validity, completeness and accuracy of our income tax provision and accounting for complex and/or non-routine transactions and the related disclosures. Accordingly, our management believes that the financial statements included in this Form 10-Q as of March 31, 2020 are fairly presented, in all material respects, and in conformity with U.S. GAAP.
Remediation Plan
We have engaged an external consultant to assist in the development and execution of a plan to remediate the material weaknesses related to our Life Sciences segment noted above. This process commenced during the second quarter of fiscal 2020 and is ongoing.
We have developed and are executing on our plan to remediate our material weaknesses in connection with the information technology controls by expanding our in-house expertise on information technology general controls, as well as continuing to consult with external third parties. This process commenced during the fourth quarter of fiscal 2018 and is ongoing.
We have also implemented a new system is effective. Theretriggered revenue recognition process for the Global Logistics Services segment based on target dates (e.g., delivery date, file transfer date, etc.) for specific file types. This process has been implemented as the second quarter of fiscal year 2020.
Our management believes that the foregoing efforts will effectively remediate the material weaknesses. That said, the new and enhanced controls have not operated for a sufficient amount of time to conclude that the material weaknesses have been remediated.  As we continue to evaluate and work to improve our internal control over financial reporting, our management may decide to take additional measures to address the material weaknesses or modify the remediation plan described above.
Internal control over financial reporting, no matter how well designed, has inherent limitations. Therefore, even those controls determined to be effective may not prevent or detect misstatements and can provide only reasonable assurance with respect to financial statement preparation and presentation. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Our executive management team, together with our board of directors, is committed to achieving and maintaining a strong control environment, high ethical standards, and financial reporting integrity.
Changes in Internal Control over Financial Reporting
As disclosed above under “Remediation Plan,” there were changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the most recent fiscal quarterperiod covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

- 18 -
In addition, as discussed above, during the quarter ended March 31, 2020, the Company implemented changes to its accounting policies, practices and internal controls over financial reporting in connection with its adoption of ASC Topic 606.

PART II - OTHER INFORMATION

ITEM 1.
LEGAL PROCEEDINGS

Janel is occasionally subject to claims and lawsuits which typically arise in the normal course of business. While the outcome of these claims cannot be predicatedpredicted with certainty, management does not believe that the outcome of any of these legal matters will have a material adverse effect on the Company’s financial position orbusiness, results of operations.

operations, financial condition or cash flows.
In December 2017, Janel Group received a Notice of Copyright Infringement letter from counsel for Warren Communications News, Inc. (“Warren”), the publisher of the International Trade Today (“ITT”) newsletter. On May 11, 2020, the parties reached a settlement agreement and release to resolve any and all concerns between the parties, voluntarily and without admission of copyright infringement.
As of March 31, 2020, the Company had a liability for settlement costs related to the Warren Matter, which is included in accrued expenses and other current liabilities.

ITEM 1A.
RISK FACTORS
For a discussion of the Company’s potential risks or uncertainties, please see “Part I—Item 1A—Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended September 30, 2019 filed with the SEC. Other than as described below, there have been no material changes to the risk factors disclosed in Part I—Item 1A of the Company’s 2019 Annual Report.
The coronavirus pandemic has significantly impacted worldwide economic conditions and has had, and is likely to continue to have, an adverse effect on our business operations, results of operations, cash flows and financial position.

In December 2019, a novel coronavirus (COVID-19) outbreak was reported in China, and, in March 2020, the World Health Organization declared such outbreak a pandemic. Since that time, the coronavirus has spread throughout the United States and globally, including in the regions and communities in which we operate. We are closely monitoring the impact of the COVID-19 pandemic on all aspects of our business and geographies, including how it has and will continue to impact our customers, suppliers, employees and other business partners. The COVID-19 pandemic has created significant volatility, uncertainty and economic disruption, which will adversely affect our business operations and has, and is likely to continue to, adversely affect our results of operations, cash flows and financial position.  COVID-19 has spread to regions that are important to our business in terms of sales, manufacturing, and our supply chain, and many of the affected regions, including the region in which our headquarters are located, are currently under government-imposed ‘stay at home’ orders which may restrict our ability to continue normal business operations.  Further, our management is focused on mitigating the effects of COVID-19 on our business operations while protecting the health of our employees, which has required and will continue to require, a significant investment of time and resources across our enterprise.
In our Global Logistics Services segment, customer demand for our services in many parts of our business has been materially and negatively impacted by the mandated closure of our customers’ operations or points of sale, while customer demand for our services in other parts of our business has increased significantly as consumers stockpile goods or switch to e-commerce platforms to make purchases. We are unable to accurately predict the impact that COVID-19 will have on our operations going forward due to uncertainties regarding the severity and duration of the outbreak and additional actions that may be taken by governmental authorities. That said, we currently expect that our results of operations and financial condition will be even more significantly adversely impacted in the third quarter and fourth quarters of 2020 and subsequent periods than in the quarter ended March 31, 2020, as levels of activity in the Company’s business have historically been positively correlated to broad measures of economic activity, such as gross domestic product, and to measures of industrial economic activity, which have been negatively impacted by the pandemic.
Additionally, we have seen a material impact in our Life Sciences business as a result of a slowdown in academic research due to the pandemic. We may also see adverse impact on our ability (a) to manufacture, test and ship our products in our Life Sciences and Manufacturing businesses, (b) to get required materials and components to make our products in our Manufacturing and Life Sciences segments, and (c) to staff labor and management for manufacturing, supply chain, research and development and administrative operations.  Further, we may experience adverse impact with our global supply chain partners and transportation service providers.  Any extended pandemic outbreak, such as is occurring with COVID-19, could cause our key third-party suppliers or the Company itself to temporarily close one or more offices or manufacturing facilities. In addition, there has been a significant decline in trade shows worldwide and also a significant decline in our ability to travel to visit current and potential customers, which will adversely affect our ability to create leads and generate business. Also, in some cases, our customers have suspended operations or limited our ability to come on-site. Furthermore, we may not be able to maintain for an extended period of time our efforts to have employees work at home and operate reduced workforces at facilities. Similarly, we may not be able to mitigate other threats to the business such as developing effective contingency plans for potential supply interruptions. Any of the foregoing events or other unforeseen consequences of public health problems could materially adversely affect our business, result of operations, prospects, and financial condition. The full extent to which the COVID-19 outbreak will impact the Company’s business and operating results will depend on future developments that are highly uncertain and cannot be accurately predicted, including new information that may emerge concerning COVID-19 and actions taken to contain its spread or its impact.
The effects of the COVID-19 pandemic may remain prevalent for a significant period of time and may continue to adversely affect our business, results of operations and financial condition even after the COVID-19 outbreak has subsided. The extent to which the COVID-19 pandemic impacts us will depend on numerous evolving factors and future developments that we are not able to predict, including: the severity and duration of the outbreak; governmental, business and other actions (which could include limitations on our operations or mandates to provide services in a specified manner); the promotion of social distancing and the adoption of shelter-in-place orders affecting our ability to provide our services; the impact of the pandemic on economic activity; the extent and duration of the effect on consumer confidence and spending, customer demand and buying patterns; the health of and the effect on our workforce and our ability to meet staffing needs, particularly if members of our workforce, including key members of management, are quarantined as a result of exposure; any impairment in value of our tangible or intangible assets which could be recorded as a result of a weaker economic conditions; and the potential effects on our internal controls including those over financial reporting as a result of changes in working environments such as shelter-in-place and similar orders that are applicable to our employees and business partners, among others. Further, provisions for bad debt expense may increase given the financial difficulty faced by our business partners, which could, among other things, impact our ability to borrow under our credit facility. In addition, if the pandemic continues to create disruptions or turmoil in the credit or financial markets, it could adversely affect our ability to continue to meet our liquidity needs, all of which are highly uncertain and cannot be predicted.
ITEM 2.
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
There were no unregistered sales of equity securities during the six months ended March 31, 2020. In addition, there were no shares of common stock purchased by us during the six months ended March 31, 2020.
ITEM 6.
EXHIBIT INDEX

Exhibit No.
  
3.1Articles of Incorporation of Wine Systems Design,Purchase and Sale Agreement dated February 4, 2020 by and between 4040 Earnings Way, LLC, and Indco, Inc. (predecessor name) (incorporated by reference to Exhibit 3A to Wine Systems Design, Inc. (predecessor name) Registration Statement on Form SB-2 filed May 10, 2001, File No. 333-60608)
3.2Restated and Amended By-Laws of Janel Corporation (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed November 1, 2013, File No. 333-60608)
3.3Certificate of Designation of Series A Convertible Preferred Stock (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed January 17, 2007 File No. 333-60608)
3.4Certificate of Designation of Series B Convertible Preferred Stock (incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K filed October 22, 2007, File No. 333-60608)
3.5Certificate of Designation of Series C Cumulative Stock (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed August 29, 2014, File No. 333-60608)
3.6Certificate of Change pursuant to NRS 78.209 (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed April 21, 2015, File No. 333-60608)
3.7Amendment to Certificate of Designation After Issuance of Class or Series pursuant to NRS 78.1955 for Series C Cumulative Preferred Stock (incorporated by reference to Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2016, File No. 333-60608)
3.8Amendment to Certificate of Designation After Issuance of Class or Series pursuant to NRS 78.1955 for Series C Cumulative Preferred Stock (incorporated by reference to Exhibit 3.7 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2017, File No. 333-60608)
3.9Certificate of Amendment to Articles of Incorporation of the Registrant (incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K filed April 21, 2015, File No. 333-60608)
10.1Janel World Trade, Ltd. 2013 Non-Qualified Stock Option Plan (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed November 1, 2013, File No. 333-60608)
10.2Janel Corporation 2017 Equity Incentive Plan (incorporatedMarch 4, 2020, as amended by reference to Exhibit 10.4 to the Company’s QuarterlyCurrent Report on Form 10-Q for the quarter ended8-K/A filed March 31, 2017, File No. 333-60608)6, 2020)
10.3 
Third Amendment to Loan and Security Agreement dated March 27, 20144, 2020 by and between Santander Bank, N.A., Janel World Trade, Ltd.Group, Inc., Honor Worldwide Logistics LLC and its subsidiaries, and Presidential Financial Corporation (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed April 2, 2014, File No. 333-60608)
10.4First Amendment to the Loan and Security Agreement, dated September 10, 2014 between Janel World Trade, Ltd. and its subsidiaries, and Presidential Financial Corporation (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed September 16, 2014, File No. 333-60608)
10.5Second Amendment to the Loan and Security Agreement, dated September 25, 2014 between Janel World Trade, Ltd. and its subsidiaries, and Presidential Financial Corporation (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed September 30, 2014, File No. 333-60608)
10.6Third Amendment to the Loan and Security Agreement, dated October 9, 2014 between Janel World Trade, Ltd. and its subsidiaries, and Presidential Financial Corporation (incorporatedMarch 4, 2020, as amended by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K8-K/A filed October 15, 2014, File No. 333-60608)March 6, 2020)
10.7 
Fourth Amendment to the Loan and Security Agreement dated August 18, 2015, by and among Janel Corporation (formerly, Janel World Trade, Ltd.), Janel Group, Inc. (formerly, the Janel Group of New York), The Janel Group of Illinois, The Janel Group of Georgia, The Janel Group of Los Angeles, Janel Ferrara Logistics, LLC, Alpha International, LP, PCL Transport, LLC and Presidential Financial Corporation (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed August 20, 2015, File No. 333-60608)
10.8Amended and Restated Demand Secured Promissory Note made by Janel Corporation (and its subsidiaries) in favor of Presidential Financial Corporation, dated August 18, 2015 (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed August 20, 2015, File No. 333-60608)
10.9Credit Agreement, effective as of February 29, 2016,April 19, 2020, by and between INDCO, Inc.Janel Corporation and First MerchantsSantander Bank, (incorporated by reference to Exhibit 10.5 toN.A., together with the Company’s Current Report on Form 8-K filed March 25, 2016, File No. 333-60608)U.S. Small Business Administration Note dated April 19, 2020.
10.10Term Loan Promissory Note, effective as of March 16, 2016, made by INDCO, Inc. payable to First Merchants Bank (incorporated by reference to Exhibit 10.6 to the Company’s Current Report on Form 8-K filed March 25, 2016, File No. 333-60608)

 - 19 -
Rule 13a-14(a)/15d-14(a) Certification of Principal Executive Officer (filed herewith)
 

10.11Rule 13a-14(a)/15d-14(a) Certification of Principal Financial Officer (filed herewith)
 
Revolving Loan Promissory Note, effective asSection 1350 Certification of February 29, 2016, made by INDCO, Inc. payable to First Merchants Bank (incorporated by reference to Exhibit 10.7 to the Company’s Current Report on Form 8-K filed March 25, 2016, File No. 333-60608)Principal Executive Officer (filed herewith)
10.12 
Security Agreement, effective asSection 1350 Certification of February 29, 2016, made by INDCO, Inc and the Company, Inc. for the benefit of First Merchants Bank (incorporated by reference to Exhibit 10.8 to the Company’s Current Report on Form 8-K filed March 25, 2016, File No. 333-60608)Principal Financial Officer (filed herewith)
10.13 Continuing Guaranty Agreement, effective as of February 29, 2016, made by Janel Corporation for the benefit of First Merchants Bank (incorporated by reference to Exhibit 10.9 to the Company’s Current Report on Form 8-K filed March 25, 2016, File No. 333-60608)
10.14101Agreement of Lease dated January 2, 2015 between 303 Merrick LLC and The Janel Group of New York, Inc. (incorporated by reference to Exhibit 10.4 to
Interactive data files providing financial information from the Company’s Quarterly Report on Form 10-Q for the quarter ended DecemberMarch 31, 2014, File No. 333-60608)
31.1Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer*
31.2Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer*
32.1Section 1350 Certifications*
101Interactive data files providing financial information from the Registrant’s Quarterly Report on Form 10-Q2020 for the quartersix months ended June 30, 2017March 31, 2020 and 2019 in XBRL (eXtensible(Extensible Business Reporting Language) pursuant to Rule 405 of Regulation S-T: (i) Consolidated Balance Sheets June 30, 2017as of March 31, 2020 and September 30, 2016,2019, (ii) Consolidated Statements of IncomeOperations for the threesix months ended June 30, 2017March 31, 2020 and 2016,2019, (iii) Consolidated Statement of Changes in Stockholders’ Equity for the six months ended March 31, 2020 and 2019, (iv) Consolidated Statements of Cash Flows for the threesix months ended June 30, 2017March 31, 2020 and 2016,2019, and (v) Notes to Unaudited Consolidated Financial Statements*
*Filed herewithStatements.

- 20 -

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Dated: August 4, 2017May 11, 2020JANEL CORPORATION
 Registrant
  
 /s/ Brendan J. KillackeyDominique Schulte
 Brendan J. KillackeyDominique Schulte
 Chairman, President and Chief Executive Officer
 
(Principal Executive Officer)

Dated: May 11, 2020
JANEL CORPORATION
Registrant
  
 /s/ Carlos PlaVincent A. Verde
 Carlos PlaVincent A. Verde
 ChiefPrincipal Financial Officer,
(Principal Financial Officer) Treasurer and Secretary

- 21 -


44